Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
Tóm tắt
Từ khóa
Tài liệu tham khảo
Dykewicz, 2000, Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients, MMWR Recomm Rep, 49, 1
Centers for Disease Control and Prevention (CDC), 1999, 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, MMWR Morb Mortal Wkly Rep, 48, 1
Bachanova, 2009, Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma, Bone Marrow Transplant, 43, 237, 10.1038/bmt.2008.313
Meijer, 2004, Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, Transpl Infect Dis, 6, 171, 10.1111/j.1399-3062.2004.00075.x
Junghanss, 2002, Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study, Blood, 99, 1978, 10.1182/blood.V99.6.1978
Junghanss, 2002, Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study, Biol Blood Marrow Transplant, 8, 512, 10.1053/bbmt.2002.v8.pm12374456
Baron, 2006, Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning, Leukemia, 20, 1690, 10.1038/sj.leu.2404335
Huss, 1996, Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia, Bone Marrow Transplant, 18, 767
Welniak, 2007, Immunobiology of allogeneic hematopoietic stem cell transplantation, Annu Rev Immunol, 25, 139, 10.1146/annurev.immunol.25.022106.141606
Gaziev, 2005, Stem cell transplantation and gene therapy for hemoglobinopathies, Curr Hematol Rep, 4, 126
Horwitz, 2001, Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft, N Engl J Med, 344, 881, 10.1056/NEJM200103223441203
Giralt, 2007, Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date, Clin Lymphoma Myeloma, 7, S102, 10.3816/CLM.2007.s.009
Oliansky, 2007, The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review, Biol Blood Marrow Transplant, 13, 1, 10.1016/j.bbmt.2006.10.024
Dreger, 2007, Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus, Leukemia, 21, 12, 10.1038/sj.leu.2404441
de Witte, 2007, Autologous stem cell transplantation in myelodysplastic syndromes, Semin Hematol, 44, 274, 10.1053/j.seminhematol.2007.08.006
Davies, 2007, An update on the management of severe idiopathic aplastic anaemia in children, Br J Haematol, 136, 549, 10.1111/j.1365-2141.2006.06461.x
Aschan, 2007, Risk assessment in haematopoietic stem cell transplantation: conditioning, Best Pract Res Clin Haematol, 20, 295, 10.1016/j.beha.2006.09.004
Leather, 2001, Infections following hematopoietic stem cell transplantation, Infect Dis Clin North Am, 15, 483, 10.1016/S0891-5520(05)70157-4
Fraser, 2007, The management and outcome of chronic graft-versus-host disease, Br J Haematol, 138, 131, 10.1111/j.1365-2141.2007.06652.x
Chaidos, 2007, Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage, Best Pract Res Clin Haematol, 20, 125, 10.1016/j.beha.2006.10.003
Baccarani, 2006, Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet, Blood, 108, 1809, 10.1182/blood-2006-02-005686
Urbano-Ispizua, 2007, Risk assessment in haematopoietic stem cell transplantation: stem cell source, Best Pract Res Clin Haematol, 20, 265, 10.1016/j.beha.2006.09.006
Petersdorf, 2007, Risk assessment in haematopoietic stem cell transplantation: histocompatibility, Best Pract Res Clin Haematol, 20, 155, 10.1016/j.beha.2006.09.001
Bjorkstrand, 2007, High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future, Semin Hematol, 44, 227, 10.1053/j.seminhematol.2007.08.010
Passweg, 2007, Autologous stem cell transplantation in autoimmune diseases, Semin Hematol, 44, 278, 10.1053/j.seminhematol.2007.08.001
Sadelain, 2004, Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease, Best Pract Res Clin Haematol, 17, 517, 10.1016/S1521-6926(04)00068-4
Leather, 2006, New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies, Blood Rev, 20, 267, 10.1016/j.blre.2006.03.001
Collin, 2001, Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients, Clin Infect Dis, 33, 947, 10.1086/322604
Powles, 2000, Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial, Lancet, 355, 1231, 10.1016/S0140-6736(00)02090-0
Wagner, 2002, Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival, Blood, 100, 1611, 10.1182/blood-2002-01-0294
Baron, 2007, Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission, Curr Opin Hematol, 14, 145, 10.1097/MOH.0b013e3280168462
Kolb, 2004, Graft-versus-leukemia reactions in allogeneic chimeras, Blood, 103, 767, 10.1182/blood-2003-02-0342
Ruggeri, 2008, NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation, Blood Cells Mol Dis, 40, 84, 10.1016/j.bcmd.2007.06.029
Dazzi, 2007, Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment, Best Pract Res Clin Haematol, 20, 311, 10.1016/j.beha.2006.10.002
Barkholt, 2006, Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe, Ann Oncol, 17, 1134, 10.1093/annonc/mdl086
Eapen, 2007, Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study, Lancet, 369, 1947, 10.1016/S0140-6736(07)60915-5
Gluckman, 2006, Donor selection for unrelated cord blood transplants, Curr Opin Immunol, 18, 565, 10.1016/j.coi.2006.07.014
Buckley, 1993, Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency, Semin Hematol, 30, 92
Aversa, 1998, Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype, N Engl J Med, 339, 1186, 10.1056/NEJM199810223391702
Aversa, 2008, Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States, Bone Marrow Transplant, 41, 473, 10.1038/sj.bmt.1705966
Storek, 2001, Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, Blood, 97, 3380, 10.1182/blood.V97.11.3380
Schmitz, 2006, Long-term outcome of patients given transplants of mobilized blood or bone marrow: a report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation, Blood, 108, 4288, 10.1182/blood-2006-05-024042
Dey, 2007, Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen, Bone Marrow Transplant, 40, 19, 10.1038/sj.bmt.1705688
Champlin, 2003, Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications, Oncology (Williston Park), 17, 94
Georges, 2003, Review of “minitransplantation”: nonmyeloablative allogeneic hematopoietic stem cell transplantation, Int J Hematol, 77, 3, 10.1007/BF02982597
Feinstein, 2001, Nonmyeloablative hematopoietic cell transplantation, Curr Opin Oncol, 13, 95, 10.1097/00001622-200103000-00003
Giralt, 2001, Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation, Blood, 97, 631, 10.1182/blood.V97.3.631
Hows, 2006, Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors, Bone Marrow Transplant, 38, 799, 10.1038/sj.bmt.1705531
Lewin, 2002, Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations, Blood, 100, 2235, 10.1182/blood.V100.6.2235
Small, 1990, B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny, Blood, 76, 1647, 10.1182/blood.V76.8.1647.1647
Storek, 2001, Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation, Blood, 98, 489, 10.1182/blood.V98.2.489
Mackall, 1997, Distinctions between CD8+ and CD4 + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy, Blood, 89, 3700, 10.1182/blood.V89.10.3700
Roux, 2000, Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity, Blood, 96, 2299, 10.1182/blood.V96.6.2299
Storek, 1997, Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts, Am J Hematol, 54, 131, 10.1002/(SICI)1096-8652(199702)54:2<131::AID-AJH6>3.0.CO;2-Y
Berger, 2008, Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality, Bone Marrow Transplant, 41, 55, 10.1038/sj.bmt.1705870
Talmadge, 2008, Lymphocyte subset recovery following allogeneic bone marrow transplantation: CD4(+)-cell count and transplant-related mortality, Bone Marrow Transplant, 41, 19, 10.1038/sj.bmt.1705871
Kim, 2006, Rapid helper T-cell recovery above 200 × 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation, Bone Marrow Transplant, 37, 1119, 10.1038/sj.bmt.1705381
Dumont-Girard, 1998, Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants, Blood, 92, 4464, 10.1182/blood.V92.11.4464
Mackall, 1995, Age, thymopoiesis, and CD4 + T-lymphocyte regeneration after intensive chemotherapy, N Engl J Med, 332, 143, 10.1056/NEJM199501193320303
Weinberg, 1995, The effect of thymic function on immunocompetence following bone marrow transplantation, Biol Blood Marrow Transplant, 1, 18
Storek, 2002, Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation, Transplantation, 73, 1154, 10.1097/00007890-200204150-00026
Hakim, 2005, Age-dependent incidence, time course, and consequences of thymic renewal in adults, J Clin Invest, 115, 930, 10.1172/JCI200522492
Myers, 2002, Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival, Blood, 99, 872, 10.1182/blood.V99.3.872
Komanduri, 2007, Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T cell skewing, Blood, 110, 4543, 10.1182/blood-2007-05-092130
Thomson, 2000, Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation, Blood, 96, 2703, 10.1182/blood.V96.8.2703
Bittencourt, 2002, Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation, Blood, 99, 2726, 10.1182/blood.V99.8.2726
Ochs, 1995, Late infections after allogeneic bone marrow transplantation: comparison of incidence in related and unrelated donor transplant recipients, Blood, 86, 3979, 10.1182/blood.V86.10.3979.bloodjournal86103979
Sullivan, 1992, Late complications of allogeneic and autologous marrow transplantation, Bone Marrow Transplant, 10, 127
Atkinson, 1982, Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease, Blood, 60, 714, 10.1182/blood.V60.3.714.714
Hakim, 1997, The immune system: effector and target of GVHD, 257
Maris, 2003, Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning, Exp Hematol, 31, 941, 10.1016/S0301-472X(03)00201-7
van Burik, 2007, Infectious complications following unrelated cord blood transplantation, Vox Sang, 92, 289, 10.1111/j.1423-0410.2007.00900.x
Cwynarski, 2001, Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation, Blood, 97, 1232, 10.1182/blood.V97.5.1232
AABB, 2007
Fact-Jacie, 2006
National Marrow Donor Program, 2004
World Marrow Donor Association, 2007
Food and Drug Administration, 2007
European Commission, 2004, Commission Directive 2004/23/EC, Official J Eur Union, L 102, 48
European Commission, 2006, Commission Directive 2006/17/EC, Official J Eur Union, L 38, 40
US National Archives and Records Administration, 2004
Centers for Disease Control and Prevention, 2007, West Nile virus transmission through blood transfusion—South Dakota, 2006, MMWR Morb Mortal Wkly Rep, 56, 76
Centers for Disease Control and Prevention, 2007, West Nile virus update—United States, January 1-November 13, 2007, MMWR Morb Mortal Wkly Rep, 56, 1191
Centers for Disease Control and Prevention, 2005, West Nile virus infections in organ transplant recipients—New York and Pennsylvania, August-September, 2005, MMWR Morb Mortal Wkly Rep, 54, 1021
Centers for Disease Control and Prevention, 2004, Transfusion-associated transmission of West Nile virus—Arizona, 2004, MMWR Morb Mortal Wkly Rep, 53, 842
Centers for Disease Control and Prevention, 2003, Detection of West Nile virus in blood donations—United States, 2003, MMWR Morb Mortal Wkly Rep, 52, 769
Centers for Disease Control and Prevention, 2003, Update: detection of West Nile virus in blood donations—United States, 2003, MMWR Morb Mortal Wkly Rep, 52, 916
Centers for Disease Control and Prevention, 2002, Investigation of blood transfusion recipients with West Nile virus infections, MMWR Morb Mortal Wkly Rep, 51, 823
Food and Drug Administration, 1999, Suitability determination for donors of human cellular and tissue-based products: proposed rule, Fed. Reg, 64, 52696
Hewitt, 2006, Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study, Vox Sang, 91, 221, 10.1111/j.1423-0410.2006.00833.x
Ludlam, 2006, Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products, Br J Haematol, 132, 13, 10.1111/j.1365-2141.2005.05796.x
Hart, 2004, Informed consent for blood transfusion: should the possibility of prion risk be included?, Transfus Med Rev, 18, 177, 10.1016/j.tmrv.2004.03.001
Llewelyn, 2004, Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion, Lancet, 363, 417, 10.1016/S0140-6736(04)15486-X
Ljungman, 2006, Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation, Haematologica, 91, 78
Nichols, 2002, High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection, J Infect Dis, 185, 273, 10.1086/338624
Matsuo, 2007, Toxoplasmosis encephalitis following severe graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group, Eur J Haematol, 79, 317, 10.1111/j.1600-0609.2007.00919.x
Kotton, 2007, Zoonoses in solid-organ and hematopoietic stem cell transplant recipients, Clin Infect Dis, 44, 857, 10.1086/511859
Slavin, 1994, Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience, Bone Marrow Transplant, 13, 549
Kitchen, 2005, Transfusion-transmitted malaria: current donor selection guidelines are not sufficient, Vox Sang, 88, 200, 10.1111/j.1423-0410.2005.00610.x
Kitchen, 2005, Documented cases of post-transfusion malaria occurring in England: a review in relation to current and proposed donor-selection guidelines, Vox Sang, 89, 77, 10.1111/j.1423-0410.2005.00661.x
Centers for Disease Control and Prevention, 2003, Probable transfusion-transmitted malaria—Houston, Texas, 2003, MMWR Morb Mortal Wkly Rep, 52, 1075
Mungai, 2001, Transfusion-transmitted malaria in the United States from 1963 through 1999, New Engl J Med, 344, 1973, 10.1056/NEJM200106283442603
Centers for Disease Control and Prevention, 1999, Transfusion-transmitted malaria—Missouri and Pennsylvania, 1996-1998, MMWR Morb Mortal Wkly Rep, 48, 253
Villeneuve, 1999, Plasmodium falciparum infection following allogeneic bone-marrow transplantation, Ann Trop Med Parasitol, 93, 533, 10.1080/00034989958285
O'Donnell, 1998, Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation, Bone Marrow Transplant, 21, 313, 10.1038/sj.bmt.1701073
Lefrere, 1996, Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation, Bone Marrow Transplant, 18, 473
Herwaldt, 2002, Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6-month period, Transfusion, 42, 1154, 10.1046/j.1537-2995.2002.00189.x
Kain, 2001, Transfusion-transmitted babesiosis in Ontario: first reported case in Canada, CMAJ, 164, 1721
Kjemtrup, 2002, Investigation of transfusion transmission of a WA1-type babesial parasite to a premature infant in California, Transfusion, 42, 1482, 10.1046/j.1537-2995.2002.00245.x
Linden, 2000, Transfusion-associated transmission of babesiosis in New York state, Transfusion, 40, 285, 10.1046/j.1537-2995.2000.40030285.x
Pantanowitz, 2002, Tick-borne diseases in transfusion medicine, Transfus Med Rev, 12, 85, 10.1046/j.1365-3148.2002.00358.x
Pantanowitz, 2002, The impact of babesiosis on transfusion medicine, Transfus Med Rev, 16, 131, 10.1053/tmrv.2002.31462
AABB, 2008
Klein, 1997, Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis, J Infect Dis, 176, 1405, 10.1086/517332
Centers for Disease Control and Prevention, 2007, Blood donor screening for chagas disease—United States, 2006-2007, MMWR Morb Mortal Wkly Rep, 56, 141
Centers for Disease Control and Prevention, 2006, Chagas disease after organ transplantation—Los Angeles, California, 2006, MMWR Morb Mortal Wkly Rep, 55, 798
Centers for Disease Control and Prevention, 2002, Chagas disease after organ transplantation—United States, 2001, MMWR Morb Mortal Wkly Rep, 51, 210
Leiby, 1999, Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion, N Engl J Med, 341, 1237, 10.1056/NEJM199910143411615
Leiby, 1997, Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors, J Infect Dis, 176, 1047, 10.1086/516534
Dodd, 1998, Transmission of parasites by blood transfusion, Vox Sang, 74, 161, 10.1111/j.1423-0410.1998.tb05415.x
Aljurf, 1999, Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients, Bone Marrow Transplantation, 24, 551, 10.1038/sj.bmt.1701930
Tavil, 2007, Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey, Pediatr Transplant, 11, 414, 10.1111/j.1399-3046.2007.00679.x
National Marrow Donor Program, 2007
Husebekk, 2004, Hepatitis B virus-infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non-infectious products, Transfusion, 44, 942, 10.1111/j.1537-2995.2004.00379.x
Reich-Slotky, 2007, Microbial pathogens of hematopoietic stem cells—screening and testing for infectious diseases, Rev Med Microbiol, 18, 17, 10.1097/MRM.0b013e3282cdf04a
Padley, 2007, Sterility testing of hematopoietic progenitor cell products: a single-institution series of culture-positive rates and successful infusion of culture-positive products, Transfusion, 47, 636, 10.1111/j.1537-2995.2007.01165.x
Majado, 2007, Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant, Xenotransplantation, 39, 121
Khuu, 2006, Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR-compliant method, Transfusion, 46, 2071, 10.1111/j.1537-2995.2006.01041.x
Klein, 2006, Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae, Biol Blood Marrow Transplant, 12, 1142, 10.1016/j.bbmt.2006.06.011
Kelly, 2006, What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?, Rev Med Microbiol, 38, 183
Kamble, 2005, Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts, Transfusion, 45, 874, 10.1111/j.1537-2995.2005.04178.x
Larrea, 2004, Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation, Haematologica, 89, 1232
Khuu, 2004, Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products, Cytotherapy, 6, 183, 10.1080/14653240410005997
Lowder, 2003, Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact, Cytotherapy, 5, 377, 10.1080/14653240310003044
Padley, 2003, Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy, Cytotherapy, 5, 147, 10.1080/14653240310001046
Honohan, 2002, Microbial contamination of cord blood stem cells, Vox Sang, 82, 32, 10.1046/j.1423-0410.2002.00133.x
Gagnon, 1998, Bacterial decontamination of blood stem cell apheresis products, J Clin Apher, 13, 103, 10.1002/(SICI)1098-1101(1998)13:3<103::AID-JCA2>3.0.CO;2-G
Espinosa, 1996, Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation, Transfusion, 36, 789, 10.1046/j.1537-2995.1996.36996420754.x
US National Archives and Records Administration, 2004
NetCord-FACT, 2006
Siegel, 2007, 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings, Am J Infect Control, 35, S65, 10.1016/j.ajic.2007.10.007
Hughes, 2002, 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer, Clin Infect Dis, 34, 730, 10.1086/339215
Gafter-Gvili, 2005, Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients, Ann Intern Med, 142, 979, 10.7326/0003-4819-142-12_Part_1-200506210-00008
van de Wetering, 2005, Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials, Eur J Cancer, 41, 1372, 10.1016/j.ejca.2005.03.006
Bucaneve, 2007, Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients, Eur J Cancer, 5, 10.1016/j.ejcsup.2007.06.002
Bucaneve, 2005, Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia, N Engl J Med, 353, 977, 10.1056/NEJMoa044097
Cruciani, 1996, Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis, Clin Infect Dis, 23, 795, 10.1093/clinids/23.4.795
Cruciani, 2003, Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients, J Clin Oncol, 21, 4127, 10.1200/JCO.2003.01.234
Engels, 1998, Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis, J Clin Oncol, 16, 1179, 10.1200/JCO.1998.16.3.1179
The European Antimicrobial Resistance Surveillance System (EARSS) Annual Report, 2006.
MacDougall, 2005, Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals, Clin Infect Dis, 41, 435, 10.1086/432056
Bonadio, 2005, Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications, Biomed Pharmacother, 59, 511, 10.1016/j.biopha.2005.06.008
Blahova, 2007, Four years of monitoring antibiotic resistance in microorganisms from bacteremic patients, J Chemother, 19, 665, 10.1179/joc.2007.19.6.665
Robicsek, 2006, The worldwide emergence of plasmid-mediated quinolone resistance, Lancet Infect Dis, 6, 629, 10.1016/S1473-3099(06)70599-0
Oktem, 2008, HITIT Project Study Group. qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey, Jpn J Infect Dis, 61, 13, 10.7883/yoken.JJID.2008.13
Poirel, 2008, Is plasmid-mediated quinolone resistance a clinically significant problem?, Clin Microbiol Infect, 14, 295, 10.1111/j.1469-0691.2007.01930.x
Loo, 2005, A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality, N Engl J Med, 353, 2442, 10.1056/NEJMoa051639
Vose, 1995, Clinical applications of hematopoietic growth factors, J Clin Oncol, 13, 1023, 10.1200/JCO.1995.13.4.1023
Moreau, 1997, Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma, J Clin Oncol, 15, 660, 10.1200/JCO.1997.15.2.660
Dekker, 2006, Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation, J Clin Oncol, 24, 5207, 10.1200/JCO.2006.06.1663
Sung, 2007, Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection, Ann Intern Med, 147, 400, 10.7326/0003-4819-147-6-200709180-00010
Rand, 1989, Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients, Bone Marrow Transplant, 4, 679
Bosi, 1990, Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients, Haematologica, 75, 109
Buckley, 1991, Use of intravenous immune globulin in immunodeficiency diseases, N Engl J Med, 325, 110, 10.1056/NEJM199107113250207
Bowden, 1994, Infection complicating bone marrow transplantation, 601
Sullivan, 1996, A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery, Biol. Blood Marrow Transplant, 2, 44
Wolff, 1993, High-dose weekly intravenous immunoglobulin to prevent infections in patients undergoing autologous bone marrow transplantation or severe myelosuppressive therapy. A study of the American Bone Marrow Transplant Group, Ann Intern Med, 118, 937, 10.7326/0003-4819-118-12-199306150-00004
Yamasaki, 2008, Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens, Transpl Infect Dis, 10, 252, 10.1111/j.1399-3062.2007.00291.x
Aksu, 2001, Aerobic bacterial and fungal infections in peripheral blood stem cell transplants, Bone Marrow Transplant, 27, 201, 10.1038/sj.bmt.1702739
Kim, 2004, Hickman catheter site infections after allogeneic stem cell transplantation: single-center experience, Transplant Proc, 36, 3203, 10.1016/j.transproceed.2004.10.089
Adler, 2006, Catheter-associated bloodstream infections in pediatric hematology-oncology patients: factors associated with catheter removal and recurrence, J Pediatr Hematol Oncol, 28, 23
Raad, 1994, Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion, Infect Control Hosp Epidemiol, 15, 231, 10.2307/30145574
Pronovost, 2006, An intervention to decrease catheter-related bloodstream infections in the ICU, N Engl J Med, 355, 2725, 10.1056/NEJMoa061115
Hanna, 2004, Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial, J Clin Oncol, 22, 3163, 10.1200/JCO.2004.04.124
Darouiche, 2005, Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial, Ann Surg, 242, 193, 10.1097/01.sla.0000171874.29934.61
Chatzinikolaou, 2003, Clinical experience with minocycline and rifampin-impregnated central venous catheters in bone marrow transplantation recipients: efficacy and low risk of developing staphylococcal resistance, Infect Control Hosp Epidemiol, 24, 961, 10.1086/502167
O'Grady, 2002, Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention, MMWR Recomm Rep, 51, 1
Gillies, 2003, Gauze and tape and transparent polyurethane dressings for central venous catheters, Cochrane Database Syst Rev, 10.1002/14651858.CD003827
Ruschulte, 2009, Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial, Ann Hematol, 88, 267, 10.1007/s00277-008-0568-7
Timsit, 2009, Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial, JAMA, 301, 1231, 10.1001/jama.2009.376
Safdar, 2006, Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials, Clin Infect Dis, 43, 474, 10.1086/505976
Raad, 1997, Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections, Clin Infect Dis, 25, 149, 10.1086/514518
Chatzinikolaou, 2003, Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer, Clin Infect Dis, 36, 116, 10.1086/344952
Betjes, 2004, Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution, Nephrol Dial Transplant, 19, 1546, 10.1093/ndt/gfh014
Broom, 2008, Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial, Scand J Infect Dis, 40, 399, 10.1080/00365540701756953
Maki, 2006, The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies, Mayo Clin Proc, 81, 1159, 10.4065/81.9.1159
American Academy of Pediatrics/Committee on Infectious Diseases, 2006, Pneumococcal infections, 525
Engelhard, 2002, Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey, Br J Haematol, 117, 444, 10.1046/j.1365-2141.2002.03457.x
Patel, 2007, Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation, Clin Infect Dis, 44, 625, 10.1086/511641
Cordonnier C, Labopin M, V C, et al. Influence of immunisation timing on the response to conjugate-pneumococcal vaccine after allogeneic stem cell transplant: final results of the EBMT IDWP01 Trial. Bone Marrow Transplant. 2008;45.
Tauro, 2000, Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma, Bone Marrow Transplant, 26, 1017, 10.1038/sj.bmt.1702647
Perez Retortillo, 1998, Pneumococcal pericarditis with cardiac tamponade in a patient with chronic graft-versus-host disease, Bone Marrow Transplant, 21, 299, 10.1038/sj.bmt.1701072
Haddad, 2002, Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature, Am J Med, 113, 152, 10.1016/S0002-9343(02)01154-3
Jenkins, 2008, Trends in antibacterial resistance among Streptococcus pneumoniae isolated in the USA: update from PROTEKT US Years 1-4, Ann Clin Microbiol Antimicrob, 7, 1, 10.1186/1476-0711-7-1
Goldman, 2006, Dental management of patients with bone marrow and solid organ transplantation, Dent Clin North Am, 50, 659, 10.1016/j.cden.2006.06.009
Prabhu, 2005, Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis, Eur J Clin Microbiol Infect Dis, 24, 832, 10.1007/s10096-005-0037-3
Alcaide, 1995, In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood, Antimicrob Agents Chemother, 39, 2243, 10.1128/AAC.39.10.2243
Steiner, 1993, Viridans streptococcal shock in bone marrow transplantation patients, Am J Hematol, 42, 354, 10.1002/ajh.2830420405
American Academy of Pediatrics. Haemophilus influenzae infections. In: LK Pickering, ed. 2006 Red Book: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:310–318.
Barra, 1992, Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients, J Infect Dis, 166, 1021, 10.1093/infdis/166.5.1021
Sable, 1994, Infections in bone marrow transplant recipients, Clin Infect Dis, 18, 273, 10.1093/clinids/18.3.273
Suzuki, 2003, Pertussis in adolescence after unrelated cord blood transplantation, Bone Marrow Transplant, 32, 967, 10.1038/sj.bmt.1704250
American Academy of Pediatrics/Committee on Infectious Diseases, 2006, Pertussis, 502
Nichols, 2003, Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products, Blood, 101, 4195, 10.1182/blood-2002-10-3143
Ljungman, 2002, Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors, Scand J Infect Dis, 34, 347, 10.1080/00365540110080412
Bowden, 1995, Comparison of filtered blood (FB) to seronegative blood products (SB) for prevention of cytomegalovirus (CMV) infection after marrow transplant, Blood, 86, 3598, 10.1182/blood.V86.9.3598.bloodjournal8693598
Blajchman, 2001, Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction, Transfus Med Rev, 15, 1, 10.1053/tmrv.2001.19946
Ratko, 2001, Evidence-based recommendations for the use of WBC-reduced cellular blood components, Transfusion, 41, 1310, 10.1046/j.1537-2995.2001.41101310.x
Goodrich, 1993, Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant, Ann Intern Med, 118, 173, 10.7326/0003-4819-118-3-199302010-00003
Prentice, 1994, Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group, Lancet, 343, 749, 10.1016/S0140-6736(94)91835-X
Ljungman, 2002, Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants, Blood, 99, 3050, 10.1182/blood.V99.8.3050
Boeckh, 1996, Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study, Blood, 88, 4063, 10.1182/blood.V88.10.4063.bloodjournal88104063
Winston, 1993, Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial, Ann Intern Med, 118, 179, 10.7326/0003-4819-118-3-199302010-00004
Fries, 2005, Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation, Biol Blood Marrow Transplant, 11, 136, 10.1016/j.bbmt.2004.11.016
Takami, 2005, High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant, Haematologica, 90, 1290
Matsumura, 2007, Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients, Biol Blood Marrow Transplant, 13, 577, 10.1016/j.bbmt.2006.12.454
Boeckh, 1996, Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation, J Infect Dis, 174, 907, 10.1093/infdis/174.5.907
Boeckh, 1998, Quantitation of cytomegalovirus: methodologic aspects and clinical applications, Clin Microbiol Rev, 11, 533, 10.1128/CMR.11.3.533
Drew, 2007, Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients, Curr Opin Infect Dis, 20, 408, 10.1097/QCO.0b013e32821f6010
Lilleri, 2007, Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of pre-emptively treated children and young adults receiving haematopoietic stem cell transplantation as compared to qualitative pp65-antigenemia, Blood, 110, 2757, 10.1182/blood-2007-03-080820
Gerna, 2003, Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial, Blood, 101, 5053, 10.1182/blood-2002-12-3636
JC Mendez, IG Sia, CV Paya. Human cytomegalovirus. In: Lennette EH, ed. Laboratory Diagnosis of Viral Infections. New York: Marcel Decker, Inc., 1999:361–372.
Goodrich, 1991, Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation, N Engl J Med, 325, 1601, 10.1056/NEJM199112053252303
Schmidt, 1991, A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group, N Engl J Med, 324, 1005, 10.1056/NEJM199104113241501
Reusser, 2002, Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation, Blood, 99, 1159, 10.1182/blood.V99.4.1159
Ayala, 2006, Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant, 37, 851, 10.1038/sj.bmt.1705341
Einsele, 2006, Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation, Blood, 107, 3002, 10.1182/blood-2005-09-3786
van der Heiden, 2006, Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients, Bone Marrow Transplant, 37, 693, 10.1038/sj.bmt.1705311
Busca, 2007, Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation, Transpl Infect Dis, 9, 102, 10.1111/j.1399-3062.2006.00183.x
Volin, 2008, An open-label randomised study of oral valganciclovir versus intravenous ganciclovir for pre-emptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation [abstract], Bone Marrow Transplant, 41, 47
Moretti, 1998, Forscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study, Bone Marrow Transplant, 22, 175, 10.1038/sj.bmt.1701302
Boeckh, 1998, Occult cytomegalovirus infection of marrow stroma, Clin Infect Dis, 26, 209, 10.1086/517022
Nichols, 2001, Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes, Blood, 97, 867, 10.1182/blood.V97.4.867
Gerna, 2005, Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients, Haematologica, 90, 526
Eckle, 2000, Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes, Blood, 96, 3286, 10.1182/blood.V96.9.3286
Cesaro, 2005, Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation, J Clin Virol, 34, 129, 10.1016/j.jcv.2005.02.009
Platzbecker, 2001, Successful preemptive cidofovir treatment for CMV antigenemia after dose-reduced conditioning and allogeneic blood stem cell transplantation, Transplantation, 71, 880, 10.1097/00007890-200104150-00010
Ljungman, 2001, Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation, Blood, 97, 388, 10.1182/blood.V97.2.388
Chou, 2008, Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir, Rev Med Virol, 18, 233, 10.1002/rmv.574
Holmberg, 1999, Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation, Blood, 94, 4029, 10.1182/blood.V94.12.4029
Boeckh, 1995, Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation, J Infect Dis, 172, 939, 10.1093/infdis/172.4.939
Peggs, 2000, Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation, Br J Haematol, 111, 782
Krause, 1997, Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease, Bone Marrow Transplant, 19, 1111, 10.1038/sj.bmt.1700801
Gor, 1998, Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease, Bone Marrow Transplant, 21, 597, 10.1038/sj.bmt.1701139
Zaia, 1997, Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma, J Infect Dis, 176, 10.1086/517301
Ljungman, 1993, Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation, Br J Haematol, 83, 118, 10.1111/j.1365-2141.1993.tb04641.x
Walter, 1995, Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor, N Engl J Med, 333, 1038, 10.1056/NEJM199510193331603
Cobbold, 2005, Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers, J Exp Med, 202, 379, 10.1084/jem.20040613
Peggs, 2003, Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines, Lancet, 362, 1375, 10.1016/S0140-6736(03)14634-X
Einsele, 2002, Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy, Blood, 99, 3916, 10.1182/blood.V99.11.3916
Buchsbaum, 1996, EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice, Immunol Lett, 52, 145, 10.1016/0165-2478(96)02602-8
Shapiro, 1988, Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation, Blood, 71, 1234, 10.1182/blood.V71.5.1234.1234
Zutter, 1988, Epstein-Barr virus lymphoproliferation after bone marrow transplantation, Blood, 72, 520, 10.1182/blood.V72.2.520.520
Gerritsen, 1996, Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children, Bone Marrow Transplant, 18, 377
Lucas, 1998, Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation, Blood, 91, 3654, 10.1182/blood.V91.10.3654
Gustafsson, 2000, Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells, Blood, 95, 807, 10.1182/blood.V95.3.807.003k24_807_814
van Esser, 2001, Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT, Blood, 98, 972, 10.1182/blood.V98.4.972
Meerbach, 2008, Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease, J Med Virol, 80, 441, 10.1002/jmv.21096
Papadopoulos, 1994, Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation, N Engl J Med, 330, 1185, 10.1056/NEJM199404283301703
Rooney, 1998, Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients, Blood, 92, 1549, 10.1182/blood.V92.5.1549
Heslop, 1999, Transfer of EBV-specific CTL to prevent EBV lymphoma post bone marrow transplant, J Clin Apher, 14, 154, 10.1002/(SICI)1098-1101(1999)14:3<154::AID-JCA9>3.0.CO;2-K
Lucas, 2000, A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants, Hum Gene Ther, 11, 1453, 10.1089/10430340050057521
Cavazzana-Calvo, 1998, Prevention of EBV-induced B-lymphoproliferative disorder by ex vivo marrow B-cell depletion in HLA-phenoidentical or non-identical T-depleted bone marrow transplantation, Br J Haematol, 103, 543, 10.1046/j.1365-2141.1998.00972.x
Saral, 1981, Acyclovir prophylaxis of herpes-simplex-virus infections, N Engl J Med, 305, 63, 10.1056/NEJM198107093050202
Gluckman, 1983, Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir, Lancet, 2, 706, 10.1016/S0140-6736(83)92248-1
Wade, 1982, Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial, Ann Intern Med, 96, 265, 10.7326/0003-4819-96-3-265
Wade, 1984, Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation, Ann Intern Med, 100, 823, 10.7326/0003-4819-100-6-823
Johnson, 1992, Hepatitis due to herpes simplex virus in marrow-transplant ecipients, Clin Infect Dis, 14, 38, 10.1093/clinids/14.1.38
Erard, 2007, Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease, J Infect Dis, 196, 266, 10.1086/518938
Smith, 1982, A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2, Antimicrob Agents Chemother, 22, 55, 10.1128/AAC.22.1.55
Langston, 2002, Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation, Blood, 99, 1085, 10.1182/blood.V99.3.1085
Nichols, 2003, Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications, J Infect Dis, 187, 801, 10.1086/367894
Dignani, 2002, Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation, Bone Marrow Transplant, 29, 263, 10.1038/sj.bmt.1703354
Eisen, 2003, Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy, Bone Marrow Transplant, 31, 51, 10.1038/sj.bmt.1703817
Erard, 2007, One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation, Blood, 110, 3071, 10.1182/blood-2007-03-077644
Dekker, 2001, Pediatric uses of valacyclovir, penciclovir and famciclovir, Pediatr Infect Dis J, 20, 1079, 10.1097/00006454-200111000-00014
Marin, 2007, Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 56, 1
Josephson, 1988, Airborne transmission of nosocomial varicella from localized zoster, J Infect Dis, 158, 238, 10.1093/infdis/158.1.238
Galea, 2008, The safety profile of varicella vaccine: a 10-year review, J Infect Dis, S165, 10.1086/522125
Oxman, 2005, A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults, N Engl J Med, 352, 2271, 10.1056/NEJMoa051016
Centers for Disease Control and Prevention (CDC), 2006, A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol, MMWR Morb Mortal Wkly Rep, 55, 209
Boeckh, 2006, Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study, Blood, 107, 1800, 10.1182/blood-2005-09-3624
Thomson, 2005, The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation, Bone Marrow Transplant, 35, 1065, 10.1038/sj.bmt.1704959
Hatchette, 2008, Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature, Pediatr Infect Dis J, 27, 75, 10.1097/INF.0b013e3181598315
Safrin, 1991, Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection, Ann Intern Med, 115, 19, 10.7326/0003-4819-115-1-19
Weinstock, 2006, Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients, Biol Blood Marrow Transplant, 12, 1096, 10.1016/j.bbmt.2006.06.005
Boeckh, 2006, Prevention of VZV infection in immunosuppressed patients using antiviral agents, Herpes, 13, 60
Adler, 2008, An outbreak of varicella with likely breakthrough disease in a population of pediatric cancer patients, Infect Control Hosp Epidemiol, 29, 866, 10.1086/590358
Merck. Varivax: Varicella Vaccine Live, 2008.
Merck. Zostavax: Zoster Vaccine Live, 2007.
Hata, 2002, Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants, N Engl J Med, 347, 26, 10.1056/NEJMoa013441
Garcia, 1997, Nosocomial respiratory syncytial virus infections: prevention and control in bone marrow transplant patients, Infect Control Hosp Epidemiol, 18, 412, 10.2307/30141248
Raad, 1997, Infection control of nosocomial respiratory viral disease in the immunocompromised host, Am J Med, 102, 48, 10.1016/S0002-9343(97)00011-9
Sable, 1995, Orthomyxoviral and paramyxoviral infections in transplant patients, Infect Dis Clin North Am, 9, 987, 10.1016/S0891-5520(20)30712-1
Whimbey, 1996, Community respiratory virus infections among hospitalized adult bone marrow transplant recipients, Clin Infect Dis, 22, 778, 10.1093/clinids/22.5.778
Whimbey, 1995, Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients, Bone Marrow Transplant, 16, 393
Folz, 1999, Coronavirus pneumonia following autologous bone marrow transplantation for breast cancer, Chest, 115, 901, 10.1378/chest.115.3.901
Fiore, 2007, Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007, MMWR Recomm Rep, 56, 1
Centers for Disease Control and Prevention (CDC), 1997, Immunization of health care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee, MMWR Morb Mortal Wkly Rep, 46, 1
Hayden, 1997, Prevention and treatment of influenza in immunocompromised patients, Am J Med, 102, 55, 10.1016/S0002-9343(97)80013-7
Engelhard, 1993, Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients, Bone Marrow Transplant, 11, 1
Fiore, 2008, Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008, MMWR Recomm Rep, 57, 1
American Academy of Pediatrics. Influenza. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:401–411.
Nichols, 2004, Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy, Clin Infect Dis, 39, 1300, 10.1086/425004
Chemaly, 2006, Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center, Medicine (Baltimore), 85, 278, 10.1097/01.md.0000232560.22098.4e
Martin, 1988, Respiratory syncytial virus infections in adult bone marrow transplant recipients, Lancet, 1, 1396, 10.1016/S0140-6736(88)92208-8
Hertz, 1989, Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature, Medicine (Baltimore), 68, 269, 10.1097/00005792-198909000-00002
Boeckh, 2007, Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients, Clin Infect Dis, 44, 245, 10.1086/509930
Khanna, 2008, Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature, Clin Infect Dis, 46, 402, 10.1086/525263
Sparrelid, 1997, Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections, Bone Marrow Transplant, 19, 905, 10.1038/sj.bmt.1700752
Ljungman, 2001, Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplant, 28, 479, 10.1038/sj.bmt.1703139
De Vincenzo, 1996, Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation, Bone Marrow Transplant, 17, 1051
de Fontbrune, 2007, Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation, Clin Infect Dis, 45, 1019, 10.1086/521912
American Academy of Pediatrics. Respiratory syncytial virus. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:560–566.
Englund, 1997, Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients, Am J Med, 102, 61, 10.1016/S0002-9343(97)00014-4
Englund, 2006, Brief communication: fatal human metapneumovirus infection in stem-cell transplant recipients, Ann Intern Med, 144, 344, 10.7326/0003-4819-144-5-200603070-00010
Wyde, 2003, Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro, Antiviral Res, 60, 51, 10.1016/S0166-3542(03)00153-0
Hamelin, 2006, Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection, Antimicrob Agents Chemother, 50, 774, 10.1128/AAC.50.2.774-777.2006
American Academy of Pediatrics. Parainfluenza viral infections. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:479–481.
American Academy of Pediatrics. Adenovirus infections. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics. 2006:202–204.
MS Horwitz. Adenoviruses. In: Knipe DM, Howley PM, ed. Fields Virology. Philadelphia, PA: Lippincott, Williams and Wilkins, 2001:2301–2326.
Flomenberg, 1995, Characterization of human proliferative T cell responses to adenovirus, J Infect Dis, 171, 1090, 10.1093/infdis/171.5.1090
La Rosa, 2001, Adenovirus infections in adult recipients of blood and marrow transplants, Clin Infect Dis, 32, 871, 10.1086/319352
Howard, 1999, Adenovirus infections in hematopoietic stem cell transplant recipients, Clin Infect Dis, 29, 1494, 10.1086/313514
Ison, 2006, Adenovirus infections in transplant recipients, Clin Infect Dis, 43, 331, 10.1086/505498
Chakrabarti, 2002, Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery, Blood, 100, 1619, 10.1182/blood-2002-02-0377
Kampmann, 2005, Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation, Br J Haematol, 130, 595, 10.1111/j.1365-2141.2005.05649.x
Lion, 2003, Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease, Blood, 102, 1114, 10.1182/blood-2002-07-2152
Flomenberg, 1994, Increasing incidence of adenovirus disease in bone marrow transplant recipients, J Infect Dis, 169, 775, 10.1093/infdis/169.4.775
Shields, 1985, Adenovirus infections in patients undergoing bone-marrow transplantation, N Engl J Med, 312, 529, 10.1056/NEJM198502283120901
Myers, 2005, Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath), Bone Marrow Transplant, 36, 1001, 10.1038/sj.bmt.1705164
Erard, 2007, Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease, Clin Infect Dis, 45, 958, 10.1086/521851
Feuchtinger, 2005, Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation, Br J Haematol, 128, 503, 10.1111/j.1365-2141.2004.05331.x
Myers, 2007, Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation, Bone Marrow Transplant, 39, 677, 10.1038/sj.bmt.1705645
van Tol, 2005, Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery, Bone Marrow Transplant, 36, 39, 10.1038/sj.bmt.1705003
Avivi, 2004, Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab, Biol Blood Marrow Transplant, 10, 186, 10.1016/j.bbmt.2003.11.001
Neofytos, 2007, Treatment of adenovirus disease in stem cell transplant recipients with cidofovir, Biol Blood Marrow Transplant, 13, 74, 10.1016/j.bbmt.2006.08.040
Yusuf, 2006, Cidofovir for the treatment of adenoviral infection in pediatric hematopoietic stem cell transplant patients, Transplantation, 81, 1398, 10.1097/01.tp.0000209195.95115.8e
Symeonidis, 2007, Invasive adenoviral infections in T-cell-depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir, Transpl Infect Dis, 9, 108, 10.1111/j.1399-3062.2006.00184.x
Morfin, 2005, In vitro susceptibility of adenovirus to antiviral drugs is species-dependent, Antivir Ther, 10, 225, 10.1177/135965350501000204
Feuchtinger, 2006, Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation, Br J Haematol, 134, 64, 10.1111/j.1365-2141.2006.06108.x
Knowles, 2006, Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV), Adv Exp Med Biol, 577, 19, 10.1007/0-387-32957-9_2
Egli, 2008, (BKV) and JC (JCV) replication in plasma and urine in healthy blood donors (Abstract #1058), Am J Transplant, 8, 460
Bofill-Mas, 2001, Potential transmission of human polyomaviruses through the gastrointestinal tract after exposure to virions or viral DNA, J Virol, 75, 10290, 10.1128/JVI.75.21.10290-10299.2001
Knowles, 1999, Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers, J Med Virol, 59, 474, 10.1002/(SICI)1096-9071(199912)59:4<474::AID-JMV9>3.0.CO;2-W
Arthur, 1986, Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants, N Engl J Med, 315, 230, 10.1056/NEJM198607243150405
Arthur, 1988, BK and JC virus infections in recipients of bone marrow transplants, J Infect Dis, 158, 563, 10.1093/infdis/158.3.563
Bedi, 1995, Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation, J Clin Oncol, 13, 1103, 10.1200/JCO.1995.13.5.1103
Gorczynska, 2005, Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation, Biol Blood Marrow Transplant, 11, 797, 10.1016/j.bbmt.2005.06.007
Hirsch, 2002, Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients, N Engl J Med, 347, 488, 10.1056/NEJMoa020439
Stracke, 2003, Polyoma virus-associated interstitial nephritis in a patient with acute myeloic leukaemia and peripheral blood stem cell transplantation, Nephrol Dial Transplant, 18, 2431, 10.1093/ndt/gfg361
Limaye, 2005, Polyomavirus nephropathy in native kidneys of non-renal transplant recipients, Am J Transplant, 5, 614, 10.1034/j.1600-6143.2003.00126.x-i1
Drachenberg, 2007, Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: a prospective evaluation, Transplantation, 84, 323, 10.1097/01.tp.0000269706.59977.a5
Kharfan-Dabaja, 2007, Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature, Bone Marrow Transplant, 39, 101, 10.1038/sj.bmt.1705548
Hix, 2004, Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid, Transplantation, 78, 1407, 10.1097/01.TP.0000137106.09925.8B
Rinaldo, 2007, Antivirals for the treatment of polyomavirus BK replication, Expert Rev Antiinfect Ther, 5, 105, 10.1586/14787210.5.1.105
Leung, 2005, Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation, Clin Infect Dis, 40, 528, 10.1086/427291
Hui, 2005, A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation, Blood, 106, 464, 10.1182/blood-2005-02-0698
Carpenter, 2002, Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale, Blood, 99, 4245, 10.1182/blood-2001-12-0239
Tur-Kaspa, 1988, The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer, Virology, 167, 630, 10.1016/0042-6822(88)90127-4
Tur-Kaspa, 1986, Hepatitis B virus DNA contains a glucocorticoid-responsive element, Proc Natl Acad Sci USA, 83, 1627, 10.1073/pnas.83.6.1627
Aksoy, 2007, Rituximab-related viral infections in lymphoma patients, Leuk Lymphoma, 48, 1307, 10.1080/10428190701411441
Moses, 2006, Lamivudine prophylaxis and treatment of hepatitis B Virus-exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab, J Med Virol, 78, 1560, 10.1002/jmv.20705
Hui, 2005, Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation, J Clin Virol, 32, 173, 10.1016/j.jcv.2004.08.003
Goyama, 2002, Reverse seroconversion of hepatitis B virus after hematopoietic stem cell transplantation, Leuk Lymphoma, 43, 2159, 10.1080/1042819021000033042
Lau, 2002, Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy, Blood, 100, 3054, 10.1182/blood-2002-07-1976
Lau, 2002, High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation, Blood, 99, 2324, 10.1182/blood.V99.7.2324
Lau, 2002, Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation, Hepatology, 36, 702, 10.1053/jhep.2002.35068
Hsiao, 2006, Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients, Biol Blood Marrow Transplant, 12, 84, 10.1016/j.bbmt.2005.09.001
Lin, 2005, Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients, Int J Hematol, 81, 349, 10.1532/IJH97.A10411
Shuhart, 1994, Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course, Blood, 84, 3229, 10.1182/blood.V84.9.3229.3229
Strasser, 1999, Hepatitis C virus infection and bone marrow transplantation: a cohort study with 10-year follow-up, Hepatology, 29, 1893, 10.1002/hep.510290609
Peffault, 2004, Long-term outcome of hepatitis C infection after bone marrow transplantation, Blood, 103, 1618, 10.1182/blood-2003-06-2145
Locasciulli, 1995, Hepatitis C virus serum markers and liver disease in children with leukemia, Leuk Lymphoma, 17, 245, 10.3109/10428199509056828
Vance, 1996, Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon, Transplantation, 62, 1358, 10.1097/00007890-199611150-00032
Surapaneni, 2007, Suppressive anti-HCV therapy for prevention of donor to recipient transmission in stem cell transplantation, Am J Gastroenterol, 102, 449, 10.1111/j.1572-0241.2006.00937.x
McDonald, 2006, Review article: management of hepatic disease following haematopoietic cell transplant, Aliment Pharmacol Ther, 24, 441, 10.1111/j.1365-2036.2006.03001.x
Hogan, 2004, Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients, Blood, 103, 78, 10.1182/blood-2003-04-1311
Peffault, 2005, Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients, Bone Marrow Transplant, 36, 709, 10.1038/sj.bmt.1705120
Yamanishi, 1988, Identification of human herpesvirus-6 as a causal agent for exanthem subitum, Lancet, 1, 1065, 10.1016/S0140-6736(88)91893-4
Zerr, 2005, Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation, Clin Infect Dis, 40, 932, 10.1086/428060
Zerr, 2005, A population-based study of primary human herpesvirus 6 infection, N Engl J Med, 352, 768, 10.1056/NEJMoa042207
Cone, 1993, Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals, J Clin Microbiol, 31, 1262, 10.1128/JCM.31.5.1262-1267.1993
Yoshikawa, 1993, Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan, J Med Virol, 41, 319, 10.1002/jmv.1890410412
Imbert-Marcille, 2000, Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients, Clin Infect Dis, 31, 881, 10.1086/318142
Ogata, 2006, Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance, J Infect Dis, 193, 68, 10.1086/498531
Sashihara, 2002, High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients, Blood, 100, 2005, 10.1182/blood.V100.6.2005
Wang, 2006, Surveillance of active human herpesvirus 6 infection in Chinese patients after hematopoietic stem cell transplantation with 3 different methods, Int J Hematol, 84, 262, 10.1532/IJH97.A10607
Ward, 2006, Human herpesvirus 6 chromosomal integration in immunocompetent patients results in high levels of viral DNA in blood, sera, and hair follicles, J Clin Microbiol, 44, 1571, 10.1128/JCM.44.4.1571-1574.2006
Seeley, 2007, Post-transplant acute limbic encephalitis: clinical features and relationship to HHV6, Neurology, 69, 156, 10.1212/01.wnl.0000265591.10200.d7
Gorniak, 2006, MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation, AJNR, 27, 887
Glosson, 2007, Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules, Virology, 365, 125, 10.1016/j.virol.2007.03.048
Zerr, 2002, Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients, Clin Infect Dis, 34, 309, 10.1086/338044
De Bolle, 2005, Update on human herpesvirus 6 biology, clinical features, and therapy, Clin Microbiol Rev, 18, 217, 10.1128/CMR.18.1.217-245.2005
de Medeiros, 2000, Kaposi's sarcoma following allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia, Acta Haematol, 104, 115, 10.1159/000039743
Bruno, 2006, Kaposi's sarcoma triggered by endogenous HHV-8 reactivation after non-myeloablative allogeneic haematopoietic transplantation, Eur J Haematol, 76, 10.1111/j.1600-0609.2005.00601.x
Gentile, 2005, Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients, J Natl Cancer Inst, 97, 1008, 10.1093/jnci/dji177
Cuzzola, 2003, Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation, Clin Infect Dis, 37, e102, 10.1086/377268
Bonnet, 2004, Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy, Cancer, 101, 317, 10.1002/cncr.20354
Spitzer, 2008, Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020, Biol Blood Marrow Transplant, 14, 59, 10.1016/j.bbmt.2007.03.014
Gabarre, 2000, High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma, Lancet, 355, 1071, 10.1016/S0140-6736(00)02041-9
Molina, 2000, High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy, Cancer, 89, 680, 10.1002/1097-0142(20000801)89:3<680::AID-CNCR25>3.0.CO;2-W
Krishnan, 2001, Autologous stem cell transplantation for HIV-associated lymphoma, Blood, 98, 3857, 10.1182/blood.V98.13.3857
Re, 2003, High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy, J Clin Oncol, 21, 4423, 10.1200/JCO.2003.06.039
Gupta, 2009, Allogeneic hematopoietic stem cell transplantation in HIV-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research (CIBMTR), Biol Blood Marrow Transplant, 15, 864, 10.1016/j.bbmt.2009.03.023
American Society of Clinical Oncology, 1994, Recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines, J Clin Oncol, 12, 2471, 10.1200/JCO.1994.12.11.2471
Riley, 1995, Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful?, Bone Marrow Transplant, 15, 469
Walsh, 1990, Role of surveillance cultures in prevention and treatment of fungal infections, NCI Monogr, 43
Trifilio, 2007, Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole, Bone Marrow Transplant, 40, 451, 10.1038/sj.bmt.1705754
Barnes, 2007, Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients, Br J Haematol, 139, 519, 10.1111/j.1365-2141.2007.06812.x
Nucci, 2001, Revisiting the source of candidemia: skin or gut?, Clin Infect Dis, 33, 1959, 10.1086/323759
Goodman, 1992, A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation, N Engl J Med, 326, 845, 10.1056/NEJM199203263261301
Slavin, 1995, Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation—a prospective, randomized, double-blind study, J Infect Dis, 171, 1545, 10.1093/infdis/171.6.1545
Marr, 2000, Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial, Blood, 96, 2055, 10.1182/blood.V96.6.2055
Pfaller, 2007, Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing, J Clin Microbiol, 45, 1735, 10.1128/JCM.00409-07
Marr, 2000, Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole, J Infect Dis, 181, 309, 10.1086/315193
Pfaller, 2004, Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to 7 systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002, J Clin Microbiol, 42, 3142, 10.1128/JCM.42.7.3142-3146.2004
Tsai, 2004, Candida glabrata erg1 mutant with increased sensitivity to azoles and to low oxygen tension, Antimicrob Agents Chemother, 48, 2483, 10.1128/AAC.48.7.2483-2489.2004
van Burik, 2004, Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation, Clin Infect Dis, 39, 1407, 10.1086/422312
Perlin, 2007, Resistance to echinocandin-class antifungal drugs, Drug Resist Update, 10, 121, 10.1016/j.drup.2007.04.002
Winston, 2003, Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial, Ann Intern Med, 138, 705, 10.7326/0003-4819-138-9-200305060-00006
Oren, 2006, A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients, Bone Marrow Transplant, 38, 127, 10.1038/sj.bmt.1705418
Ullmann, 2007, Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease, N Engl J Med, 356, 335, 10.1056/NEJMoa061098
Wingard, 2007, Results of a randomized, double-blind trial of fluconazole vs. voriconazole for the prevention of invasive fungal infections in 600 allogeneic blood and marrow transplant patients, Blood, 110, 55a, 10.1182/blood.V110.11.163.163
Bjerke, 1994, Hepatosplenic candidiasis—a contraindication to marrow transplantation?, Blood, 84, 2811, 10.1182/blood.V84.8.2811.2811
Upton, 2007, Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation, Biol Blood Marrow Transplant, 13, 760, 10.1016/j.bbmt.2007.03.005
Marr, 2004, Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants, Blood, 103, 1527, 10.1182/blood-2003-08-2644
Anaissie, 2001, Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections, Clin Infect Dis, 33, 1871, 10.1086/324501
Anaissie, 2002, Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds, Clin Infect Dis, 35, E86, 10.1086/342305
Anaissie, 2003, Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies, Blood, 101, 2542, 10.1182/blood-2002-02-0530
Anaissie, 2002, Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study, Clin Infect Dis, 34, 780, 10.1086/338958
Baddley, 2001, Invasive mold infections in allogeneic bone marrow transplant recipients, Clin Infect Dis, 32, 1319, 10.1086/319985
Marr, 2002, Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients, Clin Infect Dis, 34, 909, 10.1086/339202
Nucci, 2004, Fusarium infection in hematopoietic stem cell transplant recipients, Clin Infect Dis, 38, 1237, 10.1086/383319
Madureira, 2007, Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin, Int J Antimicrob Agents, 30, 551, 10.1016/j.ijantimicag.2007.07.026
Kanafani, 2008, Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact, Clin Infect Dis, 46, 120, 10.1086/524071
Rijnders, 2008, Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial, Clin Infect Dis, 46, 1401, 10.1086/586739
Cordonnier, 2004, Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients, Bone Marrow Transplant, 33, 943, 10.1038/sj.bmt.1704469
Glasmacher, 2003, Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients, J Clin Oncol, 21, 4615, 10.1200/JCO.2003.04.052
Krishna, 2007, Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease, Pharmacotherapy, 27, 1627, 10.1592/phco.27.12.1627
Pascual, 2008, Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes, Clin Infect Dis, 46, 201, 10.1086/524669
Cirino, 2008, Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease, Ann Intern Med, 148, 794, 10.7326/0003-4819-148-10-200805200-00018
Budak-Alpdogan, 2000, The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey, Biol Blood Marrow Transplant, 6, 370, 10.1016/S1083-8791(00)70013-9
Ip, 1998, Risk factors for pulmonary tuberculosis in bone marrow transplant recipients, Am J Respir Crit Care Med, 158, 1173, 10.1164/ajrccm.158.4.9712072
Erdstein, 2004, Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century, Transpl Infect Dis, 6, 142, 10.1111/j.1399-3062.2004.00068.x
Garces Ambrossi, 2005, Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant, Bone Marrow Transplant, 36, 741, 10.1038/sj.bmt.1705129
de la Camara, 2000, Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation, Bone Marrow Transplant, 26, 291, 10.1038/sj.bmt.1702506
Akan, 2006, Tuberculosis in stem cell transplant patients, J Hosp Infect, 62, 421, 10.1016/j.jhin.2005.09.020
Yuen, 2002, Tuberculosis in blood and marrow transplant recipients, Hematol Oncol, 20, 51, 10.1002/hon.681
Cordonnier, 2004, Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients, Clin Infect Dis, 38, 1229, 10.1086/383307
Saadeh, 2008, Mycobacterium avium complex infection after alemtuzumab therapy for chronic lymphocytic leukemia, Pharmacotherapy, 28, 281, 10.1592/phco.28.2.281
Kaplan, 2002, Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America, MMWR Recomm Rep, 51, 1
Centers for Disease Control and Prevention (CDC), 2005, Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC, MMWR Recomm Rep, 54, 1
Centers for Disease Control and Prevention (CDC), 1996, The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices, MMWR Recomm Rep, 45, 1
Targeted tuberculin testing and treatment of latent tuberculosis infection, 2000, American Thoracic Society, MMWR Recomm Rep, 49, 1
Menzies, 2007, Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research, Ann Intern Med, 146, 340, 10.7326/0003-4819-146-5-200703060-00006
Matulis, 2008, Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay, Ann Rheum Dis, 67, 84, 10.1136/ard.2007.070789
Interferon gamma release assays for latent tuberculosis infection, 2007, An Advisory Committee Statement (ACS), Can Commun Dis Rep, 33, 1
Kobashi, 2007, Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients, Eur Respir J, 30, 945, 10.1183/09031936.00040007
Lee, 2004, Tuberculosis in hematopoietic stem cell transplant recipients in Korea, Int J Hematol, 79, 185, 10.1532/IJH97.A10219
Ahmed, 2005, Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients, J Pak Med Assoc, 55, 378
2003, Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection—United States, 2003, MMWR Morb Mortal Wkly Rep, 52, 735
Kroger, 2006, General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 55, 1
Brazinsky, 1969, Pneumocystis pneumonia transmission between patients with lymphoma, JAMA, 209, 1527, 10.1001/jama.209.10.1527
Chave, 1991, Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients, AIDS, 5, 927, 10.1097/00002030-199108000-00002
Goesch, 1990, Possible transfer of Pneumocystis carinii between immunodeficient patients, Lancet, 336, 627, 10.1016/0140-6736(90)93420-T
Bensousan, 1990, Possible transfer of Pneumocystis carinii between kidney transplant recipients, Lancet, 336, 1066, 10.1016/0140-6736(90)92534-O
Ruskin, 1967, The compromised host and infection. I. Pneumocystis carinii pneumonia, JAMA, 202, 1070, 10.1001/jama.1967.03130250052007
Watanabe, 1965, Pneumocystis carinii pneumonia in a family, JAMA, 193, 685, 10.1001/jama.1965.03090080047017
Vargas, 2000, Transmission of Pneumocystis carinii DNA from a patient with P. carinii pneumonia to immunocompetent contact health care workers, J Clin Microbiol, 38, 1536, 10.1128/JCM.38.4.1536-1538.2000
Wohl, 2002, The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia, AIDS, 16, 1821, 10.1097/00002030-200209060-00016
Miller, 2002, Probable mother-to-infant transmission of Pneumocystis carinii f. sp. hominis infection, J Clin Microbiol, 40, 1555, 10.1128/JCM.40.4.1555-1557.2002
Manoloff, 2003, Risk for Pneumocystis carinii transmission among patients with pneumonia: a molecular epidemiology study, Emerg Infect Dis, 9, 132, 10.3201/eid0901.020141
Tuan, 1992, Pneumocystis carinii pneumonitis following bone marrow transplantation, Bone Marrow Transplant, 10, 267
De Castro, 2005, Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study, Bone Marrow Transplant, 36, 879, 10.1038/sj.bmt.1705149
Chen, 2003, Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation, Bone Marrow Transplant, 32, 515, 10.1038/sj.bmt.1704162
Lyytikainen, 1996, Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation, Bone Marrow Transplant, 17, 1057
Green, 2007, Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients, Cochrane Database Syst Rev, 10.1002/14651858.CD005590.pub2
Green, 2007, Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials, Mayo Clin Proc, 82, 1052, 10.4065/82.9.1052
Maltezou, 1997, Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation, Bone Marrow Transplant, 20, 879, 10.1038/sj.bmt.1700978
Sangiolo, 2005, Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study, Biol Blood Marrow Transplant, 11, 521, 10.1016/j.bbmt.2005.04.011
Link, 1993, Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT, Bone Marrow Transplant, 11, 403
Chan, 1999, Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides, J Infect Dis, 180, 369, 10.1086/314893
Souza, 1999, High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis, Clin Infect Dis, 29, 1467, 10.1086/313509
Purdy, 1984, Desensitization for sulfasalazine skin rash, Ann Intern Med, 100, 512, 10.7326/0003-4819-100-4-512
Walter E, Chauncey T, Boeckh M, Hackman B, Kennedy M, Bowden R. PCP prophylaxis after marrow transplantation: efficacy of trimethoprim-sulfamethoxazole (trim-sulfa), role of trim-sulfa desensitization and iv pentamidine [abstract 32]. In: Program and abstracts of the 33d Interscience Conference on Antimicrobial Agents and Chemotherapy (New Orleans). Washington, DC: American Society for Microbiology, 1993:125.
Vasconcelles, 2000, Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections, Biol Blood Marrow Transplant, 6, 35, 10.1016/S1083-8791(00)70050-4
Derouin, 1992, Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review, Clin Infect Dis, 15, 267, 10.1093/clinids/15.2.267
Siegel, 1971, Transmission of toxoplasmosis by leukocyte transfusion, Blood, 37, 388, 10.1182/blood.V37.4.388.388
Jurges, 1992, Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G, Bone Marrow Transplant, 9, 65
Chandrasekar, 1997, Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature. Bone Marrow Transplant Team, Bone Marrow Transplant, 19, 685, 10.1038/sj.bmt.1700736
Bretagne, 2000, Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem cell transplant recipients, Transpl Infect Dis, 2, 127, 10.1034/j.1399-3062.2000.020305.x
Martino, 2005, Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation, Clin Infect Dis, 40, 67, 10.1086/426447
Lim, 2007, Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation, J Infect, 54, e83, 10.1016/j.jinf.2006.04.013
Small, 2000, Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation, Bone Marrow Transplant, 25, 969, 10.1038/sj.bmt.1702370
Costa, 2001, Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays, Bone Marrow Transplant, 28, 527, 10.1038/sj.bmt.1703175
Ionita, 2004, MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease, AJNR Am J Neuroradiol, 25, 270
Roemer, 2001, Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience, Clin Infect Dis, 32, E1, 10.1086/317548
Foot, 1994, Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients, Bone Marrow Transplant, 14, 241
Peacock, 1995, Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis?, Bone Marrow Transplant, 15, 983
Daly, 2003, Systemic nocardiosis following allogeneic bone marrow transplantation, Transpl Infect Dis, 5, 16, 10.1034/j.1399-3062.2003.00007.x
Filice, 2005, Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations, J Lab Clin Med, 145, 156, 10.1016/j.lab.2005.01.002
van Burik, 1997, Nocardiosis after bone marrow transplantation: A retrospective study, Clin Infect Dis, 24, 1154, 10.1086/513654
Martinez Tomas, 2007, Pulmonary nocardiosis: risk factors and outcomes, Respirology, 12, 394, 10.1111/j.1440-1843.2007.01078.x
Peleg, 2007, Risk factors, clinical characteristics, and outcome of nocardia infection in organ transplant recipients: a matched case-control study, Clin Infect Dis, 44, 1307, 10.1086/514340
Liu, 1993, Strongyloidiasis and other intestinal nematode infections, Infect Dis Clin North Am, 7, 655, 10.1016/S0891-5520(20)30548-1
Conway, 1993, Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect ELISA, Trans R Soc Trop Med Hyg, 87, 173, 10.1016/0035-9203(93)90477-8
Boscolo, 2007, Evaluation of an indirect immunofluorescence assay for strongyloidiasis as a tool for diagnosis and follow-up, Clin Vaccine Immunol, 14, 129, 10.1128/CVI.00278-06
Schaffel, 2001, The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies, Am J Trop Med Hyg, 65, 346, 10.4269/ajtmh.2001.65.346
Keiser, 2004, Strongyloides stercoralis in the immunocompromised population, Clin Microbiol Rev, 17, 208, 10.1128/CMR.17.1.208-217.2004
Leiby, 1999, Trypanosoma cruzi in a low- to moderate-risk blood donor population: seroprevalence and possible congenital transmission, Transfusion, 39, 310, 10.1046/j.1537-2995.1999.39399219290.x
Sirvent-von Bueltzingsloewen, 2004, Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients, Bone Marrow Transplant, 33, 667, 10.1038/sj.bmt.1704396
Agteresch, 2007, Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation, Bone Marrow Transplant, 40, 391, 10.1038/sj.bmt.1705728
Rodriguez-Wilhelmi, 2001, Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients, Med. Clin (Barc), 116, 37
Dictar, 1998, Recipients and donors of bone marrow transplants suffering from Chagas' disease: management and preemptive therapy of parasitemia, Bone Marrow Transplant, 21, 391, 10.1038/sj.bmt.1701107
2003, Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control, Rev Soc Bras Med Trop, 36, 767, 10.1590/S0037-86822003000600024
Moraes-Souza, 1996, Strategies for prevention of transfusion-associated Chagas' disease, Transfus Med Rev, 10, 161, 10.1016/S0887-7963(96)80057-5
Altclas, 1999, Reactivation of chronic Chagas' disease following allogeneic bone marrow transplantation and successful pre-emptive therapy with benznidazole, Transpl Infect Dis, 1, 135, 10.1034/j.1399-3062.1999.010207.x
Altclas, 2005, Chagas disease in bone marrow transplantation: an approach to preemptive therapy, Bone Marrow Transplant, 36, 123, 10.1038/sj.bmt.1705006
World Health Organization, 2008
Shamsi, 2008, The stem cell transplant program in Pakistan—the first decade, Bone Marrow Transplant, 42, S114, 10.1038/bmt.2008.137
D'Alessandro, 1995, A comparison of the efficacy of insecticide-treated and untreated bed nets in preventing malaria in Gambian children, Trans R Soc Trop Med Hyg, 89, 596, 10.1016/0035-9203(95)90401-8
Hill, 2007, Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon, BMJ, 335, 1023, 10.1136/bmj.39356.574641.55
Sehulster, 2003, Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC), MMWR Recomm Rep, 52, 1
2006, American Institute of Architects Facility Guidelines Institute, AIA Academy of Architecture for Health, US Dept.of Health & Human Services
Rhame, 1984, Extrinsic risk factors for pneumonia in the patient at high risk of infection, Am J Med, 76, 42, 10.1016/0002-9343(84)90243-2
Tablan, 2004, Guidelines for preventing health-care-associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee, MMWR Recomm Rep, 53, 1
Benet, 2007, Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure, Clin Infect Dis, 45, 682, 10.1086/521378
Hahn, 2002, Efficacy of high-efficiency particulate air filtration in preventing aspergillosis in immunocompromised patients with hematologic malignancies, Infect Control Hosp Epidemiol, 23, 525, 10.1086/502101
Rice, 2001, An evaluation of hospital special-ventilation-room pressures, Infect Control Hosp Epidemiol, 22, 19, 10.1086/501819
Engelhart, 2003, Impact of portable air filtration units on exposure of haematology-oncology patients to airborne A spergillus fumigatus spores under field conditions, J Hosp Infect, 54, 300, 10.1016/S0195-6701(03)00176-2
Rutala, 1996, APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc, Am J Infect Control, 24, 313, 10.1016/S0196-6553(96)90066-8
Loo, 1996, Control of construction-associated nosocomial aspergillosis in an antiquated hematology unit, Infect Control Hosp Epidemiol, 17, 360, 10.2307/30141134
Barnes, 1989, Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation, J Hosp Infect, 14, 89, 10.1016/0195-6701(89)90110-2
Cornet, 1999, Efficacy of prevention by high-efficiency particulate air filtration or laminar airflow against Aspergillus airborne contamination during hospital renovation, Infect Control Hosp Epidemiol, 20, 508, 10.1086/501661
Thio, 2000, Refinements of environmental assessment during an outbreak investigation of invasive aspergillosis in a leukemia and bone marrow transplant unit, Infect Control Hosp Epidemiol, 21, 18, 10.1086/501691
Kistemann, 2002, Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit, Int J Hyg Environ Health, 204, 347, 10.1078/1438-4639-00106
Vilchez, 2002, Cryptococcosis in organ transplant recipients: an overview, Am J Transplant, 2, 575, 10.1034/j.1600-6143.2002.20701.x
Streifel AJ. Design and maintenance of hospital ventilation systems and the prevention of airborne infections. In: Mayhall C, ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott, Williams & Wilkins, 2004.
Walsh, 1989, Nosocomial aspergillosis: environmental microbiology, hospital epidemiology, diagnosis and treatment, Eur J Epidemiol, 5, 131, 10.1007/BF00156818
Vonberg, 2006, Nosocomial aspergillosis in outbreak settings, J Hosp Infect, 63, 246, 10.1016/j.jhin.2006.02.014
Bartley J. Prevention of infections related to construction, renovation, and demolition systems. In: Mayhall C ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott, Williams & Wilkins, 2004.
Kidd, 2007, Construction: a model program for infection control compliance, Am J Infect Control, 35, 347, 10.1016/j.ajic.2006.07.011
Srinivasan, 2002, The ability of hospital ventilation systems to filter Aspergillus and other fungi following a building implosion, Infect Control Hosp Epidemiol, 23, 520, 10.1086/502100
Berthelot, 2006, Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards, Clin Microbiol Infect, 12, 738, 10.1111/j.1469-0691.2006.01499.x
Raad, 2002, Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction, Infect Control Hosp Epidemiol, 23, 41, 10.1086/501967
Cooper, 2003, Influence of building construction work on Aspergillus infection in a hospital setting, Infect Control Hosp Epidemiol, 24, 472, 10.1086/502239
Mahieu, 2000, A prospective study on factors influencing Aspergillus spore load in the air during renovation works in a neonatal intensive care unit, J Hosp Infect, 45, 191, 10.1053/jhin.2000.0773
Weems, 1987, Construction activity: an independent risk factor for invasive aspergillosis and zygomycosis in patients with hematologic malignancy, Infect Control, 8, 71, 10.1017/S0195941700067114
Nihtinen, 2007, The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration, Bone Marrow Transplant, 40, 457, 10.1038/sj.bmt.1705749
Falvey, 2007, Ten-year air sample analysis of Aspergillus prevalence in a university hospital, J Hosp Infect, 67, 35, 10.1016/j.jhin.2007.06.008
Lai, 2001, A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling, Am J Infect Control, 29, 333, 10.1067/mic.2001.117038
Streifel, 1988, Aspergillus and construction, 198
Opal, 1986, Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction, J Infect Dis, 153, 634, 10.1093/infdis/153.3.634
Lee, 2007, Viral respiratory tract infections in transplant patients: epidemiology, recognition and management, Drugs, 67, 1411, 10.2165/00003495-200767100-00004
Curtis, 2005, Aspergillus surveillance project at a large tertiary-care hospital, J Hosp Infect, 59, 188, 10.1016/j.jhin.2004.05.017
Dettenkofer, 2004, Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review, Am J Infect Control, 32, 84, 10.1016/j.ajic.2003.07.006
Rutala, 2004, The benefits of surface disinfection, Am J Infect Control, 32, 226, 10.1016/j.ajic.2004.04.197
Gerson, 1994, Aspergillosis due to carpet contamination, Infect Control Hosp Epidemiol, 15, 221, 10.2307/30145568
Richet, 1992, Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery, Am J Epidemiol, 135, 48, 10.1093/oxfordjournals.aje.a116201
Pegues, 2001, The epidemiology of invasive pulmonary aspergillosis at a large teaching hospital, Infect Control Hosp Epidemiol, 22, 370, 10.1086/501915
Noskin, 2000, Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals, Am J Infect Control, 28, 311, 10.1067/mic.2000.108129
Mangram, 1999, Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee, Infect Control Hosp Epidemiol, 20, 250, 10.1086/501620
Passweg, 1998, Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia, Bone Marrow Transplant, 21, 1231, 10.1038/sj.bmt.1701238
Dadd, 2003, Protective isolation in hemopoietic stem cell transplants: a review of the literature and single institution experience, J Pediatr Oncol Nurs, 20, 293, 10.1177/1043454203254985
Gupta, 2004, Outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit linked to artificial nails, Infect Control Hosp Epidemiol, 25, 210, 10.1086/502380
Moolenaar, 2000, A prolonged outbreak of Pseudomonas aeruginosa in a neonatal intensive care unit: did staff fingernails play a role in disease transmission?, Infect Control Hosp Epidemiol, 21, 80, 10.1086/501739
Boszczowski, 2005, Outbreak of extended spectrum beta-lactamase-producing Klebsiella pneumoniae infection in a neonatal intensive care unit related to onychomycosis in a health care worker, Pediatr Infect Dis J, 24, 648, 10.1097/01.inf.0000168844.55898.8f
Pittet, 2000, Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme, Lancet, 356, 1307, 10.1016/S0140-6736(00)02814-2
Widmer, 2000, Replace hand washing with use of a waterless alcohol hand rub?, Clin Infect Dis, 31, 136, 10.1086/313888
Boyce, 2002, MMWR Recomm Rep, 51, 1
Bischoff, 2000, Handwashing compliance by health care workers: the impact of introducing an accessible, alcohol-based hand antiseptic, Arch Intern Med, 160, 1017, 10.1001/archinte.160.7.1017
Hugonnet, 2002, Alcohol-based hand rub improves compliance with hand hygiene in intensive care units, Arch Intern Med, 162, 1037, 10.1001/archinte.162.9.1037
National Antimicrobial Information Network. List of EPA registered products.
CDC/National Center for Infectious Diseases/Hospital Infections Program, 2000
Favero, 1991, Sterilization, disinfection, and antispsis int he hospital, 183
Johnson, 1999, Clostridium difficile, 467
Rutala, 1999, Disinfection of endoscopes: review of new chemical sterilants used for high-level disinfection, Infect Control Hosp Epidemiol, 20, 69, 10.1086/501544
Centers for Disease Control and Prevention (CDC), 1978, Nosocomial outbreak of Rhizopus infections associated with Elastoplast wound dressings—Minnesota, MMWR Morb Mortal Wkly Rep, 27, 33
Centers for Disease Control and Prevention (CDC), 1978, Follow-up on Rhizopus infections associated with Elastoplast bandages—United States, MMWR Morb Mortal Wkly Rep, 27, 243
Bryce, 1996, An outbreak of cutaneous aspergillosis in a tertiary-care hospital, Infect Control Hosp Epidemiol, 17, 170, 10.2307/30142377
McCarty, 1986, Outbreak of primary cutaneous aspergillosis related to intravenous arm boards, J Pediatr, 108, 721, 10.1016/S0022-3476(86)81051-4
Mitchell, 1996, Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors, Lancet, 348, 441, 10.1016/S0140-6736(96)05059-3
Staib, 1984, Ecological and epidemiological aspects of aspergilli pathogenic for man and animal in Berlin (West), Zentralbl Bakteriol Mikrobiol Hyg [A], 257, 240
Hutto, 1986, Isolation of cytomegalovirus from toys and hands in a day care center, J Infect Dis, 154, 527, 10.1093/infdis/154.3.527
Rogers, 2000, Rotavirus outbreak on a pediatric oncology floor: possible association with toys, Am J Infect Control, 28, 378, 10.1067/mic.2000.109908
Fleming, 2006, Toys—friend or foe? A study of infection risk in a paediatric intensive care unit, Paediatr Nurs, 18, 14, 10.7748/paed.18.4.14.s15
Davies, 2000, Bacterial colonization of toys in neonatal intensive care cots, Pediatrics, 106, E18, 10.1542/peds.106.2.e18
Buttery, 1998, Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys, Pediatr Infect Dis J, 17, 509, 10.1097/00006454-199806000-00015
Centers for Disease Control and Prevention (CDC), 2000
Bolyard, 1998, Guideline for infection control in healthcare personnel, 1998. Hospital Infection Control Practices Advisory Committee, Infect Control Hosp Epidemiol, 19, 407, 10.2307/30142429
Stover, 1998, Varicella-zoster virus: infection, control, and prevention, Am J Infect Control, 26, 369, 10.1016/S0196-6553(98)80025-4
Centers for Disease Control and Prevention (CDC), 1991, Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures, MMWR Recomm Rep, 40, 1
1997, Management of healthcare workers infected with hepatitis B virus, hepatitis C virus, human immunodeficiency virus, or other bloodborne pathogens. AIDS/TB Committee of the Society for Healthcare Epidemiology of America, Infect Control Hosp Epidemiol, 18, 349, 10.2307/30141232
Centers for Disease Control and Prevention (CDC), 2007
Keefe, 2007, Updated clinical practice guidelines for the prevention and treatment of mucositis, Cancer, 109, 820, 10.1002/cncr.22484
Barker, 1999, Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation, Support Care Cancer, 7, 17, 10.1007/s005200050217
Schubert, 1999, Oral complications, 751
Kyle, 2007, American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma, J Clin Oncol, 25, 2464, 10.1200/JCO.2007.12.1269
Lacy, 2006, Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma, Mayo Clin Proc, 81, 1047, 10.4065/81.8.1047
Migliorati, 2006, Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment, Lancet Oncol, 7, 508, 10.1016/S1470-2045(06)70726-4
Spielberger, 2004, Palifermin for oral mucositis after intensive therapy for hematologic cancers, N Engl J Med, 351, 2590, 10.1056/NEJMoa040125
Rubenstein, 2004, Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis, Cancer, 100, 2026, 10.1002/cncr.20163
Schubert, 2008, Oral graft-versus-host disease, Dent Clin North Am, 52, 79, 10.1016/j.cden.2007.10.004
Do, 1999, Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting, J Infect Dis, 179, 442, 10.1086/314592
Kool, 1998, More than 10 years of unrecognized nosocomial transmission of Legionnaires' disease among transplant patients, Infect Control Hosp Epidemiol, 19, 898, 10.2307/30142014
Oren, 2002, Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control, Bone Marrow Transplant, 30, 175, 10.1038/sj.bmt.1703628
Knirsch, 2000, An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control, Am J Med, 108, 290, 10.1016/S0002-9343(99)00459-3
Centers for Disease Control and Prevention (CDC), 1997, Sustained transmission of nosocomial Legionnaires disease—Arizona and Ohio, MMWR Morb Mortal Wkly Rep, 46, 416
Palmore TN, Stock F, White M, et al. “A cluster of cases of nosocomial legionnaires disease linked to contaminated hospital decorative water fountain” Infect Control Hosp Epidemiol. 2009 Aug;30(8):764-8.
Squier, 2005, A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience, Am J Infect Control, 33, 360, 10.1016/j.ajic.2005.01.012
Stout, 2007, Role of environmental surveillance in determining the risk of hospital-acquired legionellosis: a national surveillance study with clinical correlations, Infect Control Hosp Epidemiol, 28, 818, 10.1086/518754
Muto, 2003, SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus, Infect Control Hosp Epidemiol, 24, 362, 10.1086/502213
Dutch Workingparty Infection Prevention. Policy for Methicillin-resistant Staphylococcus aureus;The Lancet Infectious Diseases, 2005;5(10): 653-663.
Siegel, 2006, Healthcare Infection Control Practices Advisory Committee
Coia, 2006, Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities, J Hosp Infect, 63, S1, 10.1016/j.jhin.2006.01.001
Harbarth, 2008, Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients, JAMA, 299, 1149, 10.1001/jama.299.10.1149
Robicsek, 2008, Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals, Ann Intern Med, 148, 409, 10.7326/0003-4819-148-6-200803180-00003
Huang, 2006, Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia, Clin Infect Dis, 43, 971, 10.1086/507636
Ridenour, 2007, Selective use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care unit patients, Infect Control Hosp Epidemiol, 28, 1155, 10.1086/520102
Harbarth, 1999, Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant, Staphylococcus aureus. Antimicrob Agents Chemother, 43, 1412, 10.1128/AAC.43.6.1412
Simor, 2004, The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: a CIDS/CAMM position paper, Can J Infect Dis, 15, 39, 10.1155/2004/531434
Leski, 1999, Outbreak of mupirocin-resistant Staphylococci in a hospital in Warsaw, Poland, due to plasmid transmission and clonal spread of several strains, J Clin Microbiol, 37, 2781, 10.1128/JCM.37.9.2781-2788.1999
Schmitz, 1998, The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals, J Antimicrob Chemother, 42, 489, 10.1093/jac/42.4.489
Irish, 1998, Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin, J Hosp Infect, 39, 19, 10.1016/S0195-6701(98)90239-0
Udo, 2001, The spread of a mupirocin-resistant/methicillin-resistant Staphylococcus aureus clone in Kuwait hospitals, Acta Tropica, 80, 155, 10.1016/S0001-706X(01)00171-1
Bastos, 1999, Molecular characterization and transfer among Staphylococcus strains of a plasmid conferring high-level resistance to mupirocin, Eur J Clin Microbiol Infect Dis, 18, 393, 10.1007/s100960050306
Centers for Disease Control. Vancomycin-Intermediate/Resistant Staphylococcus aureus Laboratory Testing Algorithm. Atlanta, GA: CDC, 2009:1.
Centers for Disease Control and Prevention (CDC), 1995, Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC), MMWR Recomm Rep, 22, 1
NCCLS, 2004, Performance standards for antimicrobial disk susceptibility testing. Fourteenth informational supplement, NCCLS document, M100
Centers for Disease Control and Prevention (CDC), 1997, Update: Staphylococcus aureus with reduced susceptibility to vancomycin—United States, 1997, MMWR Morb Mortal Wkly Rep, 46, 813
Smith, 1999, emergence of vancomycin resistance in, Staphylococcus aureus. N Engl J Med, 340, 493, 10.1056/NEJM199902183400701
Centers for Disease Control and Prevention, 1997, Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin, MMWR Morb Mortal Wkly Rep, 46, 626
Centers for Disease Control and Prevention, 2002, Staphylococcus aureus resistant to vancomycin—United States, 2002, MMWR Morb Mortal Wkly Rep, 51, 565
Waldvogel, 1999, New resistance in Staphylococcus aureus, N Engl J Med, 340, 556, 10.1056/NEJM199902183400709
Dellit, 2007, Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship, Clin Infect Dis, 44, 159, 10.1086/510393
Avery, 2005, Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course, Bone Marrow Transplant, 35, 497, 10.1038/sj.bmt.1704821
Dubberke, 2006, Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker?, Bone Marrow Transplant, 38, 813, 10.1038/sj.bmt.1705530
Montecalvo, 1996, Bloodstream infections with vancomycin-resistant enterococci, Arch Intern Med, 156, 1458, 10.1001/archinte.1996.00440120120013
Kirkpatrick, 1999, An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit, Clin Infect Dis, 29, 1268, 10.1086/313456
Donskey, 2000, Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients, N Engl J Med, 343, 1925, 10.1056/NEJM200012283432604
Zar, 2007, A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity, Clin Infect Dis, 45, 302, 10.1086/519265
Montecalvo, 1995, Natural history of colonization with vancomycin-resistant, Enterococcus faecium. Infect Control Hosp Epidemiol, 16, 680, 10.2307/30141910
Baden, 2001, Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of “clearance”, Clin Infect Dis, 33, 1654, 10.1086/323762
Donskey, 2002, Recurrence of vancomycin-resistant Enterococcus stool colonization during antibiotic therapy, Infect Control Hosp Epidemiol, 23, 436, 10.1086/502081
Boyce, 1995, Controlling vancomycin-resistant enterococci, Infect Control Hosp Epidemiol, 16, 634, 10.2307/30141115
Pena, 1998, Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases, Antimicrob Agents Chemother, 42, 53, 10.1128/AAC.42.1.53
Troche, 2005, Detection and treatment of antibiotic-resistant bacterial carriage in a surgical intensive care unit: a 6-year prospective survey, Infect Control Hosp Epidemiol, 26, 161, 10.1086/502521
Reddy, 2007, Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia, Clin Infect Dis, 45, 846, 10.1086/521260
Gardam, 2002, Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak?, J Infect Dis, 186, 1754, 10.1086/345921
Centers for Disease Control and Prevention (CDC), 2009, Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities, MMWR Morb Mortal Wkly Rep, 58, 256
Gerding, 1995, Clostridium difficile-associated diarrhea and colitis, Infect Control Hosp Epidemiol, 16, 459, 10.2307/30141083
McFarland, 1989, Nosocomial acquisition of Clostridium difficile infection, N Engl J Med, 320, 204, 10.1056/NEJM198901263200402
Johnson, 1990, Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission, Am J Med, 88, 137, 10.1016/0002-9343(90)90462-M
Bobulsky, 2008, Clostridium difficile skin contamination in patients with C. difficile-associated disease, Clin Infect Dis, 46, 447, 10.1086/525267
Johnson, 1992, Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole. A randomized, placebo-controlled trial, Ann Intern Med, 117, 297, 10.7326/0003-4819-117-4-297
Boyce, 2006, Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs, Infect Control Hosp Epidemiol, 27, 479, 10.1086/504362
Weber, 2003, Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands, JAMA, 289, 1274, 10.1001/jama.289.10.1274
Perez, 2005, Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control, Am J Infect Control, 33, 320, 10.1016/j.ajic.2005.04.240
Mayfield, 2000, Environmental control to reduce transmission of, Clostridium difficile. Clin Infect Dis, 31, 995, 10.1086/318149
Dykewicz, 2001, Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections, Biol Blood Marrow Transplant, 7, 19S, 10.1053/bbmt.2001.v7.pm11777100
Whimbey, 1997, Community respiratory virus infections in immunocompromised patients with cancer, Am J Med, 102, 10, 10.1016/S0002-9343(97)80004-6
Harrington, 1992, An outbreak of respiratory syncytial virus in a bone marrow transplant center, J Infect Dis, 165, 987, 10.1093/infdis/165.6.987
Hillis, 1973, Adenovirus infection in West Bengal. I: persistence of viruses in infants and young children, Indian J Med Res, 61, 980
Hall, 1986, Respiratory syncytial viral infection in children with compromised immune function, N Engl J Med, 315, 77, 10.1056/NEJM198607103150201
Roghmann, 2003, Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation, Bone Marrow Transplant, 32, 1085, 10.1038/sj.bmt.1704257
Madge, 1992, Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus, Lancet, 340, 1079, 10.1016/0140-6736(92)93088-5
Vu, 2007, Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study, Clin Infect Dis, 45, 187, 10.1086/518985
Jalal, 2005, First reported outbreak of diarrhea due to adenovirus infection in a hematology unit for adults, J Clin Microbiol, 43, 2575, 10.1128/JCM.43.6.2575-2580.2005
Musher, 2003, How contagious are common respiratory tract infections?, N Engl J Med, 348, 1256, 10.1056/NEJMra021771
Nauheim, 1990, Prolonged recoverability of desiccated adenovirus type 19 from various surfaces, Ophthalmology, 97, 1450, 10.1016/S0161-6420(90)32389-8
Gordon, 1993, Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro, Ophthalmology, 100, 1835, 10.1016/S0161-6420(93)31389-8
Sattar, 2000, Activity of an alcohol-based hand gel against human adeno-, rhino-, and rotaviruses using the fingerpad method, Infect Control Hosp Epidemiol, 21, 516, 10.1086/501796
Rutala, 2006, Efficacy of hospital germicides against adenovirus 8, a common cause of epidemic keratoconjunctivitis in health care facilities, Antimicrob Agents Chemother, 50, 1419, 10.1128/AAC.50.4.1419-1424.2006
Butz, 1993, Prevalence of rotavirus on high-risk fomites in day-care facilities, Pediatrics, 92, 202, 10.1542/peds.92.2.202
Sattar, 1986, Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission, J Hyg (Lond), 96, 277, 10.1017/S0022172400066055
Gallimore, 2006, Environmental monitoring for gastroenteric viruses in a pediatric primary immunodeficiency unit, J Clin Microbiol, 44, 395, 10.1128/JCM.44.2.395-399.2006
Ansari, 1988, Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces, J Clin Microbiol, 26, 1513, 10.1128/JCM.26.8.1513-1518.1988
Lages, 2008, In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus, J Hosp Infect, 62, 159, 10.1016/j.jhin.2007.11.018
Kampf, 2005, Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus, J Hosp Infect, 60, 144, 10.1016/j.jhin.2004.12.005
Gehrke, 2004, Inactivation of feline calicivirus, a surrogate of norovirus (formerly Norwalk-like viruses), by different types of alcohol in vitro and in vivo, J Hosp Infect, 56, 49, 10.1016/j.jhin.2003.08.019
Duizer, 2004, Inactivation of caliciviruses, Appl Environ Microbiol, 70, 4538, 10.1128/AEM.70.8.4538-4543.2004
Centers for Disease Control and Prevention (CDC), 2006
Gallimore, 2005, Use of a heminested reverse transcriptase PCR assay for detection of astrovirus in environmental swabs from an outbreak of gastroenteritis in a pediatric primary immunodeficiency unit, J Clin Microbiol, 43, 3890, 10.1128/JCM.43.8.3890-3894.2005
Marshall, 2007, Molecular features of astrovirus associated with a gastroenteritis outbreak in an aged-care centre, Eur J Clin Microbiol Infect Dis, 26, 67, 10.1007/s10096-006-0250-8
Glass, 1996, The changing epidemiology of astrovirus-associated gastroenteritis: a review, Arch Virol Suppl, 12, 287, 10.1007/978-3-7091-6553-9_31
Sebire, 2004, Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient, J Clin Pathol, 57, 1001, 10.1136/jcp.2004.017178
LeBaron, 1990, Viral agents of gastroenteritis. Public health importance and outbreak management, MMWR Recomm Rep, 39, 1
RP Gaynes Horan TC. Surveillance of nosocomial infections. In: CG Mayhall, ed. Hospital Epidemiology and Infection Control. Philadelphia, PA: Lippincott Williams & Wilkins, 1999:1285–1317.
Lee, 2005, Illness transmission in the home: a possible role for alcohol-based hand gels, Pediatrics, 115, 852, 10.1542/peds.2004-0856
Sandora, 2005, A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home, Pediatrics, 116, 587, 10.1542/peds.2005-0199
Centers for Disease Control and Prevention, 2005
Masur, 2002, Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America, Ann Intern Med, 137, 435, 10.7326/0003-4819-137-5_Part_2-200209031-00002
Kerr, 2004, Assessment of the durability of medical examination gloves, J Occup Environ Hyg, 1, 10.1080/15459620490491803
Korniewicz, 2002, Performance of latex and nonlatex medical examination gloves during simulated use, Am J Infect Control, 30, 133, 10.1067/mic.2002.119512
Kim, 2007, Community respiratory virus infections in immunocompromised patients: hematopoietic stem cell and solid organ transplant recipients, and individuals with human immunodeficiency virus infection, Semin Respir Crit Care Med, 28, 222, 10.1055/s-2007-976494
Luby, 2005, Effect of handwashing on child health: a randomised controlled trial, Lancet, 366, 225, 10.1016/S0140-6736(05)66912-7
Roberts, 2000, Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial, Pediatrics, 105, 738, 10.1542/peds.105.4.738
Ryan, 2001, Handwashing and respiratory illness among young adults in military training, Am J Prev Med, 21, 79, 10.1016/S0749-3797(01)00323-3
White, 2003, The effect of hand hygiene on illness rate among students in university residence halls, Am J Infect Control, 31, 364, 10.1016/S0196-6553(03)00041-5
Lau, 2004, SARS transmission, risk factors, and prevention in Hong Kong, Emerg Infect Dis, 10, 587, 10.3201/eid1004.030628
Chatterjee, 2007, A modified “cover your cough” campaign prevents exposures of employees to pertussis at a children's hospital, Am J Infect Control, 35, 489, 10.1016/j.ajic.2007.02.008
Centers for Disease Control and Prevention, 2000, Legionnaires' Disease associated with potting soil—California, Oregon, and Washington, May-June 2000, MMWR Morb Mortal Wkly Rep, 49, 777
Lopez, 2000, Preventing congenital toxoplasmosis, MMWR Recomm Rep, 49, 59
O'Connor, 2007, Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia, Epidemiol Infect, 135, 34, 10.1017/S095026880600656X
De Groote, 2006, Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils, Appl Environ Microbiol, 72, 7602, 10.1128/AEM.00930-06
Wilson, 1998, Saksenaea vasiformis breast abscess related to gardening injury, Aust N Z J Med, 28, 845, 10.1111/j.1445-5994.1998.tb01573.x
Golledge, 1995, An infection from a penetrating plant wound, Aust Fam Phys, 24, 2099
Siddiqui, 2007, Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease, Clin Infect Dis, 45, 673, 10.1086/520985
Stark, 2007, Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course, J Med Microbiol, 56, 699, 10.1099/jmm.0.47069-0
Praz-Christinaz, 2007, Occupational risk assessment of aspergillosis after renal transplantation, Transpl Infect Dis, 9, 175, 10.1111/j.1399-3062.2007.00223.x
Glenn, 2005, Coccidioidomycosis in hematopoietic stem cell transplant recipients, Med Mycol, 43, 705, 10.1080/13693780500147840
Blair, 2007, Coccidioidomycosis in patients who have undergone transplantation, Ann N Y Acad Sci, 1111, 365, 10.1196/annals.1406.009
Centers for Disease Control and Prevention, 2003, Increase in coccidioidomycosis—Arizona, 1998-2001, MMWR Morb Mortal Wkly Rep, 52, 109
Lyon, 2004, Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999, Am J Trop Med Hyg, 70, 438, 10.4269/ajtmh.2004.70.438
Huhn, 2005, Two outbreaks of occupationally acquired histoplasmosis: more than workers at risk, Environ Health Perspect, 113, 585, 10.1289/ehp.7484
Centers for Disease Control and Prevention, 2004, Outbreak of histoplasmosis among industrial plant workers—Nebraska, 2004, MMWR Morb Mortal Wkly Rep, 53, 1020
Jie, 2005, Mycobacterial infections after kidney transplant, Transplant Proc, 37, 10.1016/j.transproceed.2004.12.167
Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, 55, 1
Lavoie, 2006, Exposure to aerosolized bacteria and fungi among collectors of commercial, mixed residential, recyclable and compostable waste, Sci Total Environ, 370, 23, 10.1016/j.scitotenv.2006.05.016
Prevots, 2000, Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 49, 1
Parashar, 2006, Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 55, 1
Vesikari, 2006, A randomized, double-blind study of the safety, transmissibility and phenotypic and genotypic stability of cold-adapted influenza virus vaccine, Pediatr Infect Dis J, 25, 590, 10.1097/01.inf.0000220229.51531.47
Araujo, 2007, Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants, J Pediatr (Rio J), 83, 217
Ruiz-Palacios, 2006, Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis, N Engl J Med, 354, 11, 10.1056/NEJMoa052434
Clinical Review for STN 125265/0 Rotarix; 2008.
Ali, 2004, Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist), Clin Infect Dis, 38, 760, 10.1086/382887
Talbot, 2005, Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults, Infect Control Hosp Epidemiol, 26, 494, 10.1086/502574
Cha, 2000, Genotypic stability of cold-adapted influenza virus vaccine in an efficacy clinical trial, J Clin Microbiol, 38, 839, 10.1128/JCM.38.2.839-845.2000
Buonagurio, 2006, Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting, Virology, 347, 296, 10.1016/j.virol.2005.11.006
ACIP Provisional Recommendations for use of Zoster Vaccine. 2008.
Diaz, 1991, Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings, Pediatrics, 87, 166
Centers for Disease Control and Prevention (CDC). “Crypto”—Cryptosporidiosis: prevention—immunocompromised persons. 2008.
Angulo, 1994, Caring for pets of immunocompromised persons, J Am Vet Med Assoc, 205, 1711, 10.2460/javma.1994.205.12.1711
Glaser, 1994, Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus, Clin Infect Dis, 18, 14, 10.1093/clinids/18.1.14
Dalton, 1995, Iguana-associated salmonellosis in children, Pediatr Infect Dis J, 14, 319, 10.1097/00006454-199504000-00014
Centers for Disease Control and Prevention (CDC), 2003, Reptile-associated salmonellosis—selected states, 1998-2002, MMWR Morb Mortal Wkly Rep, 52, 1206
Mermin, 1997, Iguanas and Salmonella marina infection in children: a reflection of the increasing incidence of reptile-associated salmonellosis in the United States, Pediatrics, 99, 399, 10.1542/peds.99.3.399
Centers for Disease Control and Prevention (CDC), 2000, Salmonellosis associated with chicks and ducklings—Michigan and Missouri, Spring 1999, MMWR Morb Mortal Wkly Rep, 49, 297
Adams, 1998, Animals in schools: a zoonosis threat?, Pediatr Infect Dis J, 17, 174, 10.1097/00006454-199802000-00025
Berkelman, 2003, Human illness associated with use of veterinary vaccines, Clin Infect Dis, 37, 407, 10.1086/375595
DiSalvo, 2006, Who let the dogs out? Infection control did: utility of dogs in health care settings and infection control aspects, Am J Infect Control, 34, 301, 10.1016/j.ajic.2005.06.005
Centers for Disease Control and Prevention (CDC), 1996, Lake-associated outbreak of Escherichia coli O157:H7—Illinois, 1995, MMWR Morb Mortal Wkly Rep, 45, 437
Centers for Disease Control and Prevention (CDC), 1998, Outbreak of cryptosporidiosis associated with a water sprinkler fountain—Minnesota, 1997, MMWR Morb Mortal Wkly Rep, 47, 856
Kramer, 1998, First reported outbreak in the United States of cryptosporidiosis associated with a recreational lake, Clin Infect Dis, 26, 27, 10.1086/516271
Centers for Disease Control and Prevention (CDC), 2008
van Kraaij, 2000, Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients, Bone Marrow Transplant, 26, 299, 10.1038/sj.bmt.1702484
American Academy of Pediatrics, 2003, Cryptosporidiosis, 123
American Public Health Association, 2004
Keene, 1997, A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk, J Infect Dis, 176, 815, 10.1086/517310
Shen, 2008, Diagnostic and therapeutic challenges of childhood brucellosis in a nonendemic country, Pediatrics, 121, e1178, 10.1542/peds.2007-1874
Vojdani, 2008, Juice-associated outbreaks of human illness in the United States, 1995 through 2005, J Food Protein, 71, 356, 10.4315/0362-028X-71.2.356
Gardner, 2008, Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia, J Clin Oncol, 26, 5684, 10.1200/JCO.2008.16.4681
Handle and Prepare Food Safely, 2008.
Todd, 1997, Epidemiology of foodborne diseases: a worldwide review, World Health Stat Q, 50, 30
The Big Thaw—Safe Defrosting Methods for Consumers, 2008.
Moe, 1990, Low-microbial diets for patients with granulocytopenia, 125
Aker, 2000, Nutritional support of patients with hematologic malignancies, 1501
Moody, 2002, The neutropenic diet: what's the evidence?, J Pediatr Hematol Oncol, 24, 717, 10.1097/00043426-200212000-00007
Centers for Disease Control and Prevention (CDC), 2003, Outbreaks of Salmonella serotype enteritidis infection associated with eating shell eggs—United States, 1999-2001, MMWR Morb Mortal Wkly Rep, 51, 1149
Sazawal, 2006, Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials, Lancet Infect Dis, 6, 374, 10.1016/S1473-3099(06)70495-9
Falagas, 2007, Probiotics for the treatment of women with bacterial vaginosis, Clin Microbiol Infect, 13, 657, 10.1111/j.1469-0691.2007.01688.x
Antony, 1996, Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis, Clin Infect Dis, 23, 773, 10.1093/clinids/23.4.773
Oliver, 1996, Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine, Clin Infect Dis, 22, 521, 10.1093/clinids/22.3.521
Centers for Disease Control and Prevention (CDC), 2007
Centers for Disease Control and Prevention (CDC), 1998, Outbreak of acute febrile illness among athletes participating in triathlons—Wisconsin and Illinois, 1998, MMWR Morb Mortal Wkly Rep, 47, 585
Centers for Disease Control and Prevention (CDC), 1997, Outbreak of leptospirosis among white-water rafters—Costa Rica, 1996, MMWR Morb Mortal Wkly Rep, 46, 577
Sejvar, 2003, Leptospirosis in “Eco-Challenge” athletes, Malaysian Borneo, 2000, Emerg Infect Dis, 9, 702, 10.3201/eid0906.020751
Leder, 2005, Respiratory infections during air travel, Intern Med J, 35, 50, 10.1111/j.1445-5994.2004.00696.x
Centers for Disease Control and Prevention (CDC), 2008
Centers for Disease Control and Prevention (CDC). Water Treatment Methods. Atlanta, GA: Centers for Disease Control and Prevention.
Ljungman, 1995, Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplant, 15, 455
Ljungman, 2005, Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT, Bone Marrow Transplant, 35, 737, 10.1038/sj.bmt.1704870
Ljungman, 1989, Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine, J Infect Dis, 159, 610, 10.1093/infdis/159.4.610
Ljungman, 1990, Response to tetanus toxoid immunization after allogeneic bone marrow transplantation, J Infect Dis, 162, 496, 10.1093/infdis/162.2.496
Pauksen, 1992, Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation, Bone Marrow Transplant, 9, 427
Pauksen K, V H, Ljungman P, et al. Immunity to poliovirus and immunization with inactivated poliovaccine after autologous bone marrow transplantation. Clin Infect Dis. 1994;18:547–552.
Guinan, 1994, Polysaccharide conjugate vaccine responses in bone marrow transplant patients, Transplantation, 57, 677, 10.1097/00007890-199403150-00009
Youssef, 2007, Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005, Medicine, 86, 69, 10.1097/md.0b013e31803eb176
Locksley, 1985, Infection with varicella-zoster virus after marrow transplantation, J Infect Dis, 152, 1172, 10.1093/infdis/152.6.1172
Nakano, 1996, Clinical features of measles in immunocompromised children, Acta Paediatr Jpn, 38, 212, 10.1111/j.1442-200X.1996.tb03472.x
Machado, 2002, Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil, Blood, 99, 83, 10.1182/blood.V99.1.83
Kumar, 2007, A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients, Clin Infect Dis, 45, 1576, 10.1086/523583
Machado, 2005, Influenza infections after hematopoietic stem cell transplantation, Clin Infect Dis, 41, 273, 10.1086/431304
Parkman, 2003, Immunological reconstitution following hematopoietic stem cell transplantation, 853
Storek, 2004, Immunological reconstitution after hemopoietic stem cell transplantation, 194
Horwitz, 2004, Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma, Blood, 103, 777, 10.1182/blood-2003-04-1257
Nordoy, 2001, Humoral immunity to viral and bacterial antigens in lymphoma patients 4-10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines, Bone Marrow Transplant, 28, 681, 10.1038/sj.bmt.1703228
Pauksen, 2000, Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients, Clin Infect Dis, 30, 342, 10.1086/313663
Gandhi, 2001, Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients, Bone Marrow Transplant, 28, 775, 10.1038/sj.bmt.1703239
van der Velden, 2005, Development of functional Haemophilus influenzae type b antibodies after vaccination, Haematologica, 90, 1582
Meisel, 2007, Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation, Blood, 109, 2322, 10.1182/blood-2006-06-032284
Molrine, 2003, Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation, Blood, 101, 831, 10.1182/blood-2002-03-0832
Cordonnier, 2008, Immune response to the 23-valent polysaccharide pneumococcal vaccine (PPV23) after the 7-valent conjugate vaccine (PCV7) in allogeneic stem cell transplant (SCT) recipients: results of the EBMT IDWP01 trial, Blood, 112, 350, 10.1182/blood.V112.11.350.350
Papadopoulos, 2008, Use of the tetanus toxoid, reduced dose diphtheria and pertussis vaccine (Tdap) in allogeneic transplant (alloHCT) recipients [Abstract], Blood, 112, 2214, 10.1182/blood.V112.11.2214.2214
Small TN, Zelenetz AD, Noy A, et al. Pertussis Immunity and Response to tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) following autologous peripheral blood stem cell transplantation. Biol Blood Marrow Transplant (in press)
Parkkali, 2001, Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients, Bone Marrow Transplant, 27, 79, 10.1038/sj.bmt.1702742
Mahler, 2008, Immunogenicity of the tetravalent protein-conjugated meningococcal vaccine in recipients of related and unrelated allogeneic hematopoietic cell transplants (HCT) [Abstract], Blood, 112, 1163, 10.1182/blood.V112.11.1163.1163
Geddes, 2007, Immune reconstitution following hematopoietic stem-cell transplantation, Best Pract Res Clin Haematol, 20, 329, 10.1016/j.beha.2006.09.009
Joao, 2006, Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma, Bone Marrow Transplant, 37, 865, 10.1038/sj.bmt.1705342
Savani, 2007, Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation, Biol Blood Marrow Transplant, 13, 1216, 10.1016/j.bbmt.2007.07.005
Savani, 2006, Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia, Blood, 107, 1688, 10.1182/blood-2005-05-1897
Baron, 2004, Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning, Blood, 104, 2254, 10.1182/blood-2004-04-1506
Storek, 2000, Low B cell and monocyte counts on day 80 are associated with high infection rates between day 100 and 365 after allogeneic marrow transplantation, Blood, 96, 3290, 10.1182/blood.V96.9.3290
Novitzky, 2002, Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome, Transplantation, 74, 1551, 10.1097/00007890-200212150-00012
Boeckh, 2006, Immune monitoring with iTAg (TM) MHC tetramers for prediction of recurrent or persistent CMV infection in allogeneic stem cell transplant recipients: a prospective multicenter clinical trial, Biol Blood Marrow Transplant, 12, 79, 10.1016/j.bbmt.2005.11.248
Porrata, 2008, Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study, Biol Blood Marrow Transplant, 14, 807, 10.1016/j.bbmt.2008.04.013
Chang, 2008, Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies, Biol Blood Marrow Transplant, 14, 323, 10.1016/j.bbmt.2007.12.497
Rocha, 2002, Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation, Blood, 100, 3908, 10.1182/blood-2002-04-1033
Holler, 2006, Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination, Blood, 107, 4189, 10.1182/blood-2005-09-3741
Dickinson, 2007, Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics, Best Pract Res Clin Haematol, 20, 189, 10.1016/j.beha.2006.10.004
Bochud, 2008, Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation, N Engl J Med, 359, 1766, 10.1056/NEJMoa0802629
Manning, 2008, Human rabies prevention—United States, 2008: recommendations of the Advisory Committee on Immunization Practices, MMWR Recomm Rep, 57, 1
American Academy of Pediatrics. Rabies. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:552–559.
Fiore, 2006, Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 55, 1
Monto AS, Robinson DP, Herlocher ML, M. HJ, Jr., Elliott MJ, Crisp A. Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. JAMA. 1999;282:31–35.
Hayden, 1999, Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza, N Engl J Med, 341, 1336, 10.1056/NEJM199910283411802
Prevots, 2000, Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm Rep, 49, 1
American Academy of Pediatrics. Poliovirus infections. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:542–547.
Burks, 1986, Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA, N Engl J Med, 314, 560, 10.1056/NEJM198602273140907
Stiehm, 1997, Human intravenous immunoglobulin in primary and secondary antibody deficiencies, Pediatr Infect Dis J, 16, 696, 10.1097/00006454-199707000-00012
American Academy of Pediatrics. Passive Immunization. In: LK Pickering, ed. Red Book: 2006 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics, 2006:54–55.
Abe, 2003, Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation, Bone Marrow Transplant, 32, 1107, 10.1038/sj.bmt.1704276
Cheng, 2004, Ribavirin for SARS in children, Clin.Pediatr. (Phila), 43, 193, 10.1177/000992280404300211
Naquira, 1989, Ivermectin for human strongyloidiasis and other intestinal helminths, Am J Trop Med Hyg, 40, 304, 10.4269/ajtmh.1989.40.304
Belay, 1999, Reye's syndrome in the United States from 1981 through 1997, N Engl J Med, 340, 1377, 10.1056/NEJM199905063401801
Centers for Disease Control and Prevention (CDC), 1998, Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus: principles of therapy and revised recommendations. Centers for Disease Control and Prevention, MMWR Recomm Rep, 47, 1
American Academy of Pediatrics, 2006, Tuberculosis, 678